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Abstract:
The interaction between splicing factors and the transcriptional machinery provides an intriguing
link between the coupled processes of transcription and splicing. Here, we show that two 
components of the SF3B complex that forms part of the U2 small nuclear ribonucleoprotein 
particle (snRNP), SF3B3 and SF3B5, are also subunits of the Spt-Ada-Gcn5 acetyltransferase
(SAGA) transcriptional coactivator complex in Drosophila melanogaster. Whereas SF3B3 had
previously been identified as a human SAGA subunit, SF3B5 had not been identified as a 
component of SAGA in any species. We show that SF3B3 and SF3B5 bind to SAGA
independent of RNA, and interact with multiple SAGA subunits including Sgf29 and Spt7 in a 
yeast two-hybrid assay. Through analysis of sf3b5 mutant flies, we show that SF3B5 is
necessary for proper development and cell viability, but not for histone acetylation. Although 
SF3B5 does not appear to function in SAGA’s histone modifying activities, SF3B5 is still
required for expression of a subset of SAGA-regulated genes independent of splicing. Thus, our
data support an independent function of SF3B5 in SAGA’s transcription coactivator activity that
is separate from its role in splicing.
Keywords:






































































        
     
  
       
 
 
       
     
       
         
        
         
         
          
          
      
          
           
           
        
         
       
           
            
              
             
          
           
          
Abbreviations:
H3K9ac, acetylated histone H3 Lysine 9; GFP, green fluorescent protein; HAT, histone
acetyltransferase; ubH2B, monoubiquitinated histone H2B; MudPIT, Multidimensional Protein 
Identification Technology; qRT-PCR, quantitative reverse transcription polymerase chain 
reaction; RNAse, ribonuclease; SAGA, Spt-Ada-Gcn5 acetyltransferase; snRNP, small nuclear
ribonucleoprotein particle.
Introduction:
Splicing occurs co-transcriptionally and is affected by transcription rate, chromatin modifications,
and nucleosome occupancy [1-8]. Emerging evidence suggests that components involved in 
splicing can also modulate transcription [9-11]. Moreover, several splicing factors have been
shown to interact with chromatin remodelers [12], histone marks [13-16], or RNA polymerase II
itself [17], indicating that there are multiple mechanisms that couple transcription to splicing.
One intriguing link between splicing and transcription is provided by components that are
present both in the spliceosome machinery and in transcriptional regulators. For example, a
major component of the spliceosome, the U1 snRNA, interacts with the general transcription 
initiation factor TFIIH to stimulate transcription initiation [10]. In addition, the U2 small nuclear
ribonucleoprotein particle (snRNP) interacts with the transcription elongation factor TAT-SF1,
and extracts depleted for U2 snRNP show a decrease in transcriptional activity [11]. Further, the
SF3B3 (Splicing Factor 3b, subunit 3) subunit of the SF3B complex within the U2 snRNP
associates with the transcription factors ERG and TFIIS [18, 19]. Strikingly, SF3B3 is also a
subunit of the mammalian Spt-Ada-Gcn5-acetyltransferase (SAGA) transcriptional co-activator
complex [20, 21]. Thus, SF3B3 functions as a shared subunit of the U2 snRNP and SAGA.
SF3B3 is highly conserved from yeast to humans, and its homolog in Saccharomyces 
cerevisiae, Rse1, is an essential gene that is necessary for proper splicing [22-25]. SF3B3 
functions as part of the SF3B complex that contributes to recognition of the intron branch site in 
the pre-mRNA by the U2 snRNP during the first step of splicing [26-29]. Whereas the SF3B
complex itself plays a well-defined role in the first step of splicing, the function of its SF3B3
subunit that is shared with SAGA, either in splicing or in transcription, has not been well defined. 
Here, we report the identification of a second SF3B component, SF3B5 (Splicing Factor 3b,
subunit 5), as a subunit of SAGA in Drosophila melanogaster. Since our study shows that two 
2
 
































































           
       
          
           
        
       
          
          
     
         
         
  
          
          
            
           
          
        
   
          
          
        
            
        
            
      
     
           
         
        
        
independent SF3B subunits are components of metazoan SAGA, we sought to determine the
function of these shared SF3B subunits in SAGA. SAGA is highly conserved from yeast to 
humans and possesses several distinct activities that regulate different aspects of transcription
activation [30]. First, SAGA contains the histone acetyltransferase Gcn5 that acetylates histone
H3 [31]. Gcn5 is also found in a second transcriptional coactivator complex in flies and humans,
the Ada2a-containing complex (ATAC) that is distinct from SAGA [32]. Second, SAGA contains 
a histone deubiquitinase, Ubp8 (Nonstop in Drosophila), that deubiquitinates monoubiquitinated
histone H2B (ubH2B) [33]. Independent of these histone modifying activities, SAGA is also a 
direct coactivator that recruits RNA polymerase II to promoters [34, 35]. Although SAGA is best
characterized with regard to its roles at promoters, SAGA also co-localizes with RNA 
polymerase II on transcribed regions [36-38]. Thus, SAGA and the SF3B complex share a
common spatial and temporal distribution during the coupled processes of transcription and
splicing.
In this study, we examine the function of the shared SAGA/U2 snRNP subunit, SF3B5, in 
SAGA-regulated histone modification and gene expression. We show that SF3B5 is required for
expression of a subset of SAGA-regulated genes, including a gene that contains no introns in its
coding region, but is not required for SAGA-mediated histone acetylation. Thus, our findings are
consistent with a function for SF3B5 in SAGA-dependent transcription but not histone
modification, independent of its function in the U2 snRNP.
Results and Discussion:
Identification of two SF3B proteins within the Drosophila SAGA complex
To identify novel Drosophila SAGA subunits, we isolated SAGA using tandem FLAG-HA affinity
purification from S2 cell nuclear extracts with the SAGA-specific subunits Spt3 and Spt20 as 
bait proteins and examined the composition of affinity purified SAGA by Multidimensional
Protein Identification Technology (MudPIT) [39]. Purifications using the SAGA-specific subunits
Ada2b (isoform PB), ATXN7, Ada1, SAF6, WDA and the shared ATAC/SAGA subunit Sgf29 as
bait proteins were previously described and are shown for comparison [40, 41]. Peptides from
two proteins were consistently identified in affinity-purified SAGA: CG11985 and CG13900. 
These two proteins correspond to components of the U2 snRNP spliceosomal complex: SF3B3
(Splicing Factor 3b subunit 3, GeneID: CG13900; FlyBase ID: FBgn0035162) and SF3B5 
(Splicing Factor 3b subunit 5, GeneID: CG11985; FlyBase ID: FBgn0040534) (Fig. 1a, Table 1) 




































































        
     
          
           
          
          
      
        
           
        
          
   
            
        
        
          
         
        
         
  
        
            
          
       
             
         
           
            
              
         
             
abundance factor) levels to those of the core SAGA subunits Spt7 and TAF9, and were not
identified in control purifications from cells expressing a non-specific tagged bait protein, or in 
samples from cells lacking tagged protein (Fig. 1a, Supplemental Table S1).
To determine whether these splicing proteins were indeed SAGA subunits, we purified tagged
SF3B5 from S2 cell nuclear extract and analyzed the resulting complexes by MudPIT. FLAG-HA 
tandem affinity chromatography of SF3B5 co-purifies all of the known subunits of both the
SAGA and the U2 snRNP complexes (Fig. 1a, Table 1, SF3B5 bait column). Although MudPIT 
analysis of purified SF3B5 identifies all known SAGA subunits, TAF12 is significantly under-
represented and was identified in only one of the two technical replicate MudPIT analyses. It is 
unclear whether this is due to interference of the FLAG-HA epitope tag on SF3B5 with the
binding of TAF12 to SAGA, or if SF3B5-SAGA complexes indeed contain reduced levels of
TAF12. Despite this, our observations indicate that SF3B3 and SF3B5 are bona fide subunits of
both SAGA and the U2 snRNP.
SF3B3 had previously been identified as a component of the mammalian SAGA complex [20,
21], but SF3B5 represents a novel subunit of SAGA. Additionally, both SF3B3 and SF3B5 were 
identified as interacting with mammalian Sgf29 (CCDC101) [44], which is a shared subunit of
the Gcn5-containing SAGA and ATAC complexes [30]. Thus, these data collectively support
that both SF3B3 and SF3B5 are subunits of metazoan SAGA. Notably, neither SF3B3 (Rse1)
nor SF3B5 (Ysf3) associate at detectable levels with TAP-purified SAGA or SLIK in S.
cerevisiae [45]. Thus, the presence of spliceosomal proteins within SAGA appears to be unique
to higher eukaryotes.
SF3B3 and SF3B5 are independent subunits of SAGA and the U2 snRNP
Since SF3B3 and SF3B5 are known components of the SF3B complex within the larger U2
snRNP spliceosomal machinery [46, 47], we next asked whether SAGA and other U2 snRNP
subunits were physically associated. To do this, we examined the SAGA-specific purifications 
for the presence of other SF3B proteins, SF3A complex subunits, Sm proteins, or the U2B
protein itself. Additional components of the U2 snRNP were not identified reproducibly in 
purifications using the SAGA-specific subunits Ada2B (isoform PB), Spt3, Spt20, ATXN7, Ada1,
SAF6 or WDA (Fig. 1a, Supplemental Table S1). This indicates that the majority of SAGA does
not stably associate with other subunits of the SF3B complex or the larger U2 snRNP under the
conditions used for our purifications. However, affinity purifications of the shared ATAC and
SAGA subunit Sgf29 contained low numbers of peptides for many of the components of the U2 
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snRNP (Fig. 1a, Supplemental Table S1). This suggests that there is potential cross-talk 
between the U2 snRNP and a subset of SAGA complexes involving Sgf29. It is unlikely that this 
represents an interaction between the U2 snRNP and the alternative Gcn5-containing complex,
ATAC, because SF3B3 and SF3B5 are not detected in purifications using ATAC-specific
subunits as bait [48]. Further, when we purify the U2 snRNP using U2B as bait protein, we only
identify proteins from the U2 snRNP spliceosomal complex including SF3B and SF3A complex
subunits (Fig. 1a, Table 1). Although one peptide for TAF9 is identified in the U2B purification, 
we do not identify peptides from any other SAGA subunits including Sgf29 (Table 1). Thus,
SF3B3 and SF3B5 are independently associated with SAGA and the U2 snRNP, and do not
mediate a stable interaction between these two complexes under the conditions used for our
purifications.
SF3B5-containing SAGA complexes acetylate histones
We next asked whether SF3B5-purified SAGA complexes had histone acetyltransferase (HAT) 
activity. To do this, we performed HAT assays using SF3B5-purified SAGA complex on HeLa 
core histones as substrate. SF3B5-purified SAGA demonstrated HAT activity on core histones 
(Fig. 1b), predominantly on histone H3 and to a lesser extent on histone H4 (Fig. 1c). This HAT 
activity shows a similar histone preference to SAGA purified through SAGA-specific subunits 
such as SAF6 or WDA [40, 49]. Since the SF3B5-complex HAT assays were performed as part
of the same set of HAT assays described in Weake et al. (2009) for WDA and SAF6-purified
SAGA, we can compare the HAT activity of these SAGA complexes on histones [40]. Notably, 
the level of HAT activity of SF3B5-purified SAGA is 2 – 3 fold lower than that of SAGA purified
using the core SAGA subunits WDA or SAF6 as bait proteins. However, the SF3B5-purified
complex also contains much lower levels of Gcn5 relative to WDA or SAF6-purified SAGA
because SF3B5 also co-purifies components of the U2 snRNP in addition to SAGA (compare
dNSAF values for Gcn5 in each purification in Supplemental Table S1). Our data therefore
indicate that SF3B5-containing SAGA complexes contain the full complement of SAGA subunits 
and are capable of acetylating histones in a SAGA-specific pattern, suggesting that these
complexes purified through SF3B5 represent functional SAGA complexes.
The association of SF3B3 and SF3B5 with SAGA does not require RNA
Next, we sought to determine if the association of SF3B3 and SF3B5 with SAGA requires the
presence of RNA since the U2 snRNA is a core component of the U2 snRNP [50]. To do this,
we isolated SAGA from S2 cell nuclear extracts in the presence and absence of ribonuclease
5
 


































































         
         
         
           
       
              
         
        
          
          
      
      
        
            
        
       
             
          
              
           
           
        
       
        
              
        
             
            
        
          
      
          
(RNAse) using tandem FLAG-HA affinity chromatography against the bait protein WDA. RNAse
treatment reduces nucleic acids in the soluble nuclear extract to levels that are not detectable
by ethidium bromide staining following agarose gel electrophoresis (Fig. 2a). However, the
composition of SAGA purified via WDA from nuclear extract treated with RNAse appears 
identical to SAGA purified in the absence of RNAse by SDS-PAGE and silver staining (Fig. 2b). 
To examine whether SF3B3 and SF3B5 remained present in SAGA following RNAse treatment,
we examined the composition of SAGA purified in the presence of RNAse by MudPIT analysis.
Notably, similar levels of peptides as determined by spectral counts for SF3B3 and SF3B5 are 
observed in the SAGA purifications from nuclear extract treated with RNAse relative to the
untreated nuclear extract (Fig. 2c). Thus, the association of SF3B3 and SF3B5 with SAGA does 
not require RNA. This finding is consistent with the lack of annotated RNA-interacting domains
in SF3B3 and SF3B5, and with observations that suggest that SF3B3 and SF3B5 are not
directly involved in pre-mRNA branch-point recognition [28].
SF3B3 and SF3B5 interact with Sgf29 and Spt7 in SAGA
Since the incorporation of SF3B3 and SF3B5 within SAGA is independent of RNA, we next
sought to identify the protein subunits in SAGA that interacted with these spliceosomal proteins. 
We hypothesized that SF3B3 and SF3B5 would interact with SAGA-specific subunits, since
these proteins are not found in the related ATAC complex [48]. To test the pair-wise interaction
between SF3B3, SF3B5 and each SAGA subunit, we performed a yeast two-hybrid assay with
17 of the characterized Drosophila SAGA subunits as prey, and either SF3B3 or SF3B5 as bait.
We did not analyze the SAGA subunit Tra1 (NippedA), which is also a component of the
Drosophila Tip60 complex [51], in this assay due to the large size of its coding sequence and
high probability of auto-activation. When we examined the pair-wise interaction of SF3B3 and
SF3B5 by yeast two-hybrid analysis, we observed a strong reciprocal interaction between 
SF3B3 and SF3B5 (Fig. 3a). Importantly, neither SF3B3 nor SF3B5 auto-activate transcription
of the reporter genes since co-expression of either SF3B3 or SF3B5 fused to the Gal4 DNA-
binding domain (DBD) with the plasmid encoding the Gal4 Activating Domain (AD) alone does 
not result in growth on selective media (Fig. 3a, left column). We next examined the interaction
of SF3B3 and SF3B5 with the 17 SAGA subunits. The SAGA subunits assayed also do not
auto-activate reporter gene transcription because co-expression of SAGA subunits fused to the
AD with the plasmid encoding the DBD alone does not result in growth on selective media (Fig. 
3a, top row). Interestingly, we observed interactions between SF3B5 and several proteins within 






































































         
        
       
        
          
             
           
        
            
         
       
          
       
          
         
        
          
     
         
      
        
         
      
        
       
        
          
           
    
          
         
         
between SF3B3 and SAGA subunits, with only Sgf29, Spt7, and WDA showing growth on 
selective media (Fig. 3a). The binding of Spt20 to SF3B3 was unable to be determined because 
we did not observe a consistent growth phenotype. Since Sgf29 and Spt7 were identified as 
interacting with both SF3B3 and SF3B5, these proteins provide the most likely candidates for
SAGA subunits that mediate the incorporation of these two spliceosomal subunits into the
SAGA complex. This finding is not consistent with our hypothesis since Sgf29 is also a subunit
of the Gcn5-containing ATAC complex. Because the yeast two-hybrid assay tests binding of
proteins in vivo, we cannot exclude the possibility that the interaction between Drosophila SAGA
subunits and SF3B3 or SF3B5 is mediated by endogenous yeast proteins. Despite this caveat, 
the results from this yeast two-hybrid assay indicate that Sgf29 and Spt7, potentially in 
conjunction with some of the HAT module subunits and core components Spt3, Spt20 and
WDA, provide a binding surface for SF3B3 and SF3B5 within Drosophila SAGA.
The interaction of SF3B3 with Sgf29 and Spt7 is mediated by different domains
Since the association of SF3B3 and SF3B5 with SAGA is observed in Drosophila and humans,
but not in S. cerevisiae, we wondered whether there were differences in the yeast and
metazoan versions of these proteins that might account for this differential interaction. To 
examine this possibility, we first compared yeast, Drosophila and human SF3B5 using BLAST 
[52]. Yeast Ysf3 shares 53% sequence similarity with Drosophila SF3B5 and 50% sequence
similarity with human SF3B5, while Drosophila and human SF3B5 share 91% sequence
similarity. Additionally, there are no identifiable domains in any of the SF3B5 orthologs. Next, we 
compared yeast, Drosophila and human SF3B3. While Drosophila and human SF3B3 share
86% sequence similarity, yeast Rse1 shares 42% sequence similarity with Drosophila SF3B3. 
However, the N-terminal region of Drosophila and human SF3B3 contains a domain that is 
absent in yeast: the Mono-functional DNA-alkylating methyl methanesulfonate (MMS1) domain 
(Fig. 3b). The MMS1 domain is found in proteins that protect against replication-dependent DNA 
damage [53]. A second domain, the cleavage and polyadenylation specificity factor (CPSF) 
domain, whose namesake is necessary for proper 3’ end processing and pre-mRNA splicing
[54], is conserved in all three species (Fig. 3b). Since the MMS1 domain of Drosophila and 
human SF3B3 is not present in yeast SF3B3, we hypothesized that this domain is required for
binding of SF3B3 to SAGA in Drosophila. 
To test if the N-terminal region of Drosophila SF3B3 that contains the MMS1 domain was 
necessary for its binding within SAGA, we repeated our yeast two-hybrid analysis with the N-






































































          
        
    
        
               
      
        
         
           
        
      
         
              
      
      
            
             
          
            
           
           
         
   
             
         
           
         
        
       
             
        
            
proteins. The bait proteins used in this assay consist of full length SF3B3 (SF3B3-FL), the N-
terminal domain of SF3B3 (SF3B3-N, aa1 - 746) and the C-terminal domain of SF3B3 (SF3B3-
C, aa747 – 1227). Consistent with our previous yeast two-hybrid analysis, we observe growth 
on selective media when SF3B5, Sgf29 or Spt7 are co-expressed with full-length SF3B3.
However, surprisingly we did not observe an interaction between SF3B5 and either the SF3B3 
N- or C-terminal regions (Fig. 3c), indicating that neither of these domains are sufficient for this
interaction. This lack of interaction is unlikely to be due to expression problems, since we 
observe interactions between the SF3B3 C-terminal domain (SF3B3-C) and Spt7, and the
SF3B3 N-terminal domain (SF3B3-N) and Sgf29 respectively. Thus, in the yeast two-hybrid
assay, the C-terminal region of SF3B3 that contains the conserved CPSF domain is sufficient to
interact with Spt7, whereas the N-terminal region of SF3B3 that contains the metazoan-specific 
MMS1 domain is sufficient to interact with Sgf29. This unexpected result indicates that the
presence of the MMS1 domain in metazoan SF3B3 is not sufficient to account for the presence 
of SF3B3 in Drosophila SAGA but not yeast SAGA. Thus, both the N- and C-terminal regions of
SF3B3 contribute to its association with SAGA through independent binding to Spt7 and Sgf29.
SF3B5 is necessary for proper development and cell viability
Whereas SAGA is not essential for viability in S. cerevisiae, mutations that disrupt SAGA in 
Drosophila are lethal during the larval or early pupal stages of development [40, 41, 49, 55-59]. 
To determine if SF3B5 was also required for development, we sought to identify a loss of
function mutation in the SF3B5 gene. We identified a P-element insertion in the coding region of
the intronless SF3B5 gene, EY12579 [60] (Fig. 4a). We were only able to identify flies carrying
the balancer chromosome in this stock, suggesting that this insertion is homozygous lethal. We
will hereafter refer to flies carrying this EY12579 transposon insertion as sf3b5EY12579 mutant
flies (Supplemental Table S2).
To determine if the lethality in the sf3b5EY12579 flies resulted from loss of SF3B5 function, we 
generated transgenic flies that express wild-type SF3B5 under GAL4/UAS regulatory control
(UAS-SF3B5) [61]. We then crossed flies carrying the sf3b5EY12579 allele and the UAS-SF3B5
transgene with sf3b5EY12579 flies that also ubiquitously express GAL4 under control of the
Actin5C promoter as outlined in Figure 4b. Since the UAS-SF3B5 transgene and actin5C-GAL4
driver are on chromosome 2, and the sf3b5EY12579 allele is on chromosome 3, there are four
different potential phenotypes in the resulting progeny from this cross: Half of the progeny will
have the actin5C-Gal4 driver on chromosome 2 and will therefore express UAS-SF3B5






































































        
         
          
           
             
          
             
           
            
           
        
          
           
       
           
          
        
      
        
           
            
 
           
           
            
           
         
           
        
        
            
       
UAS-SF3B5. In each of these halves of the resulting progeny, flies will also either be
homozygous or heterozygous for the sf3b5EY12579 allele on chromosome 3, which can be
distinguished by the presence of the stubble marker on the MKRS balancer chromosome. As
expected since the sf3b5EY12579 allele is homozygous lethal, 100% of CyO progeny from this 
cross contained the stubble marker, indicating presence of the balancer chromosome (Fig. 4b).
If expression of the UAS-SF3B5 transgene is sufficient to rescue viability of the sf3b5EY12579 
mutant, then we would expect to see adult progeny that lack the stubble marker only in those 
flies that also lack the CyO balancer chromosome, as determined by the curly wing marker.
When we examined the flies that lacked the CyO balancer chromosome, we found that 9% of
flies without the CyO balancer also lacked the stubble marker, indicating that expression of
SF3B5 rescues lethality of the sf3b5EY12579 allele (Fig. 4b). Thus we conclude that the lethality
associated with the sf3b5EY12579 allele is due to loss of function of SF3B5.
Mutations in other SAGA subunits result in lethality in different stages of larval development,
most probably due to residual maternal load of mRNAs for these subunits. For example, ada2b
and nonstop homozygotes die as pupae, gcn5 homozygotes die as third instar larvae, and saf6
and wda homozygotes die as second instar larvae [40, 49, 57, 62, 63]. To compare sf3b5EY12579 
flies with other SAGA mutants, we sought to determine the developmental stage at which 
homozygous sf3b5EY12579 flies die. To do this, we generated flies that carried the sf3b5EY12579 
allele over a balancer chromosome marked with the green fluorescent protein (GFP). We then
identified homozygous sf3b5EY12579 embryos by lack of GFP expression. We observed growth of
homozygous sf3b5EY12579 embryos until the first instar larval stage, but we did not observe any
further growth, indicating that loss of SF3B5 results in lethality at the first instar larval stage of
development. 
Since SF3B5 is necessary for viability on an organismal level, we next wanted to determine if
SF3B5 is also necessary for cell viability. In yeast, YSF3 is an essential gene for growth, 
suggesting that the function of SF3B5 in splicing plays a critical role for cell survival [24, 25]. To 
test whether SF3B5 is necessary for cell viability in Drosophila, we generated mosaic flies that
are heterozygous for sf3b5EY12579 in all tissues except the eyes, in which the cells are
homozygous for the sf3b5EY12579 allele [64]. Using this approach, we would expect to observe full
or partial eye ablation in flies carrying homozygous sf3b5EY12579 cells in the eye if SF3B5 is 
necessary for cell viability or cell division. As a control, we generated eyes carrying two copies 
of a non-essential transgene, GFP, on an otherwise wild-type chromosome. The eyes of these


































































          
         
            
         
    
          
         
         
            
           
           
         
    
          
           
        
           
       
          
        
       
      
          
     
            
       
             
          
       
  
sf3b5EY12579 showed dramatic eye ablation (Fig. 4c). To quantify this eye ablation, we measured
the width of these eyes in each genotype (n = 4) and found that sf3b5EY12579 eyes were 
approximately four-fold smaller than those of the wild-type (GFP) control (Fig. 4d). Since these
results indicate that SF3B5 is likely to be required for cell viability, we next asked if SAGA
subunits were also required for cell viability. To do this, we generated mosaic flies using the
same approach that contain eyes homozygous for a mutation in Ada2B. Ada2b is a SAGA-
specific subunit that interacts with Gcn5 and is necessary for H3 acetyltransferase activity by
SAGA [62, 65]. In contrast to sf3b5EY12579 , ada2b eyes are similar in size to the GFP control (Fig. 
4c, d). Similar results were observed for nonstop mutations that disrupt the deubiquitinase
activity of SAGA (data not shown). Thus, we conclude that SF3B5, but not other SAGA
subunits, is required for cell viability. This finding is consistent with the essential role of SF3B3 
(Rse1) and SF3B5 (Ysf3) in yeast, and suggests that the requirement of SF3B5 for cell viability
in Drosophila results from its function in splicing rather than in SAGA.
SF3B5 is not necessary for H3 acetylation
Although SF3B5’s function in splicing is likely to be more critical for cell function, we wondered
whether SF3B5 is also required for any of the known activities of SAGA. SAGA has well
characterized histone modifying activities including its HAT activity toward predominantly
histone H3 Lysine 9 (H3K9ac) and Lysine 14, and deubiquitinase activity against ubH2B. To 
determine if SF3B5 is required for SAGA’s HAT or deubiquitinase activities, we compared levels 
1118of H3K9ac and ubH2B in sf3b5EY12579 mutant larvae with those of wild-type (OregonR or w ) 
larvae. As controls, we also examined ubH2B and H3K9ac levels in nonstop and wda mutants,
which disrupt SAGA deubiquitinase activity and HAT activity resulting in elevated ubH2B levels 
in late third instar larvae, and decreased levels in H3K9ac in embryos respectively [49, 58].
To do this, we first acid extracted histones from wild-type, sf3b5EY12579 and nonstop first instar
larvae and performed western blotting analysis using antibodies against H3K9ac and histone 
H2B (Fig. 5a). Based on this analysis, we find that sf3b5EY12579 larvae show no change in global
H3K9ac levels as compared to wild-type first instar larvae (H3K9ac/H2B ratio is 113% of wild-
type levels) (Fig. 5a). In contrast, mutations in wda that disrupt SAGA HAT activity [49] result in 
a clear decrease in H3K9ac to 51% of wild-type levels (H3K9ac/H2B ratio) by the end of





































































            
       
        
         
         
       
        
         
        
          
        
     
        
        
           
            
         
        
       
     
       
       
          
          
          
         
      
            
         
        
             
Next, we examined ubH2B levels in sf3b5EY12579 larvae using antibodies specific for ubH2B
relative to histone H3. As a control for the specificity of the ubH2B antibody, we examined
ubH2B levels in acid-extracted histones from sgf11 third instar larvae. Histones from sgf11 third 
instar larvae have ~370% of ubH2B relative to the wild type, indicating that we can detect an
increase in ubH2B in SAGA deubiquitinase mutants [58]. However, neither sf3b5EY12579 nor
nonstop first instar larvae show strong increases in ubH2B levels relative to wild-type larvae
(ubH2B/H3 ratios of 99% and 130% of wild-type levels in sf3b5EY12579 and nonstop respectively)
(Fig. 5a). Previously, we were also unable to detect an increase in ubH2B levels in sgf11 
embryos [36]. These data suggest that it is not possible to detect strong global changes in the
accumulation of ubH2B at first instar larvae when SAGA deubiquitinase activity is defective, 
potentially due to the lag in accumulation of this modification. Thus, based on this analysis, we 
cannot conclude definitively whether SF3B5 is required for SAGA deubiquitinase activity.
SF3B5 is necessary for SAGA-activated expression of some SAGA-regulated genes
Although SF3B5 is not required for SAGA’s HAT activity, it is possible that SF3B5 could function
in transcription coactivation by SAGA independent of histone modification. Several studies in
yeast have shown that SAGA is required for recruitment of the general transcription factors such
as TBP to promoters independent of its HAT activity [66, 67]. In addition, the Drosophila SAGA
subunit SAF6 is required for SAGA-regulated gene expression independent of either HAT or
deubiquitinase activity [40]. Therefore, we sought to determine if SF3B5 is necessary for
SAGA’s function in activating gene expression. To test this, we examined transcript levels of 
SAGA-regulated genes in sf3b5EY12579 embryos using quantitative reverse transcription
polymerase chain reaction (qRT-PCR) analysis. We had previously identified several SAGA-
regulated genes that were co-regulated by the core SAGA subunits SAF6 and WDA in late 
stage embryos [40]. Thus, we compared transcript levels of a subset of these SAGA-regulated
genes in the sf3b5EY12579 embryos with those in wda and wild-type (OregonR) embryos.
First, we examined transcript levels of the SF3B5 and wda genes in each genotype. We 
observe lower transcript levels of SF3B5 and wda genes in the sf3b5EY12579 and wda mutants 
respectively, as compared to the wild type (OregonR). However, levels of RpL32, which has 
previously been shown not to be regulated by SAGA [36, 40, 68], were similar in all three
genotypes (99% and 127% of wild type in wda and sf3b5EY12579 respectively). Notably,
sf3b5EY12579 embryos have about 80% of wild-type levels of transcript encoding the core SAGA
subunit WDA (Fig. 5b). However, it is unlikely that this decrease in transcript results in a strong
11
 


































































     
       
             
           
      
     
      
         
       
           
  
         
             
        
              
            
          
        
       
        
        
           
           
           
           
      
          
         
       
         
       
          
decrease in WDA protein levels since in contrast to wda mutants, H3K9ac levels are not
reduced in sf3b5EY12579 larvae (Fig. 5a).
Next, we examined transcript levels of six SAGA-regulated genes that were previously shown to 
require WDA for full expression in late stage embryos [40]. Notably, four out of the six genes,
Oda, Sap47, exba and Crc, were downregulated in both sf3b5EY12579 and wda embryos relative 
to the wild type (Fig. 5b, Supplemental Table S3). While most of these genes were 
downregulated to similar levels in both mutants relative to the wild type, Sap47 showed
significantly stronger downregulation in sf3b5 relative to wda embryos (Supplemental Table S3).
Interestingly, two of the seven genes examined, CG5390 and Gp150, were significantly
downregulated (p-value < 0.05) in wda embryos but not in sf3b5EY12579 embryos (Fig. 5b, 
Supplemental Table S3). This suggests that SF3B5 is required for full expression of a subset of
SAGA-regulated genes.
Since splicing affects transcript levels, SF3B5 could be required for full expression of these 
SAGA-regulated genes either through its role in SAGA or in the U2 snRNP. Thus, to test
whether loss of SF3B5 affected splicing at these SAGA-regulated genes, we examined levels of 
unspliced transcripts relative to spliced transcripts at Oda, Sap47, exba and Crc (Fig. 5c). To do
this, we generated cDNA using random hexamer primers and performed qRT-PCR with primers
that anneal within an exon and its adjacent intron to amplify an intron/exon boundary (unspliced
transcript). As a control, we used primers that anneal within two adjacent exons to amplify the
spliced transcript. Notably, we observe a large increase in unspliced Sap47 transcript in 
sf3b5EY12579 embryos relative to the wild-type control (Fig. 5c). This is consistent with the
stronger reduction in Sap47 expression in sf3b5EY12579 embryos relative to wda embryos, and
suggests that SF3B5 is required for proper splicing of this SAGA-regulated gene. However, in 
contrast to the results observed for Sap47, we do not detect an increase in unspliced transcript 
levels for three of the SAGA-regulated genes tested, Oda, exba and Crc (Fig. 5c). This result
indicates that SF3B5 is required for full expression of these three genes through its role in 
SAGA rather than in the U2 snRNP.
Next, we asked if SF3B5 would only function to regulate gene expression in the context of
active splicing. To test this, we examined transcript levels of Sas10, which does not contain any
introns, in sf3b5EY12579 embryos. Levels of Sas10 transcripts were significantly lower (p-value <
0.05, Supplemental Table S3) in both sf3b5EY12579 and wda embryos relative to the wild type
(Fig. 5b). This result indicates that SF3B5 can regulate gene expression at genes that lack 
introns. However, since the SF3B complex is known to play a role in pre-mRNA processing
12
 
































































       
   
   
        
           
         
        
     
        
           
        
        
       
      
         
      
           
               
   
   
  
        
      
           
        
       
          
         
       
       
         
events of intronless genes [69], and since splicing factors can be required for nuclear export of
intronless mRNAs [70], it is possible that SF3B5 regulates Sas10 expression via U2 snRNP-
mediated processing rather than SAGA-regulated transcription. Further studies would be 
required to distinguish between these possibilities.
Together, our observations indicate that SF3B5 is required for proper transcriptional activation 
of a subset of SAGA-regulated genes, independent of active splicing. It is not clear however,
why genes respond differently to SF3B5 relative to other SAGA subunits. Future global analysis 
of the transcriptome of sf3b5EY12579 embryos relative to other SAGA mutants may provide insight 
into the role that SF3B5 plays in SAGA-activated gene expression.
One potential indirect explanation for the decrease in SAGA-regulated gene expression in 
sf3b5EY12579 mutants is if SF3B5 is required for splicing of SAGA subunits, thereby affecting
levels of these proteins. However, our data argue against an indirect role for SF3B5 in affecting
SAGA coactivation activity through regulating levels of SAGA subunits such as WDA. Whereas 
mutations in wda reduce global levels of H3K9ac in late stage embryos (Fig. 5a), we do not
observe a decrease in global levels of histone acetylation in sf3b5EY12579 embryos, suggesting 
that SAGA remains intact and functional with regards to HAT activity and recruitment to gene 
promoters. In addition, transcript levels of the genes encoding the deubiquitinase module of
SAGA, e(y)2, nonstop, sgf11 and Atxn7, are not reduced in sf3b5EY12579 first instar larvae (Fig.
5d). Thus, we conclude that SF3B5 is likely to be required directly for expression of a subset of
SAGA-regulated genes.
SF3B5 is required for SAGA-regulated gene expression independent of histone
acetylation and splicing
In this study we identify the spliceosomal components SF3B3 and SF3B5 as subunits of
Drosophila SAGA. A previous study had identified a potential role for SF3B3 in the recruitment
of SAGA to UV-damaged DNA [20] while this finding was not supported in a second study [21].
However, a second component of the SF3B complex, SF3B1, interacts with BRCA1 following
DNA damage to enhance splicing of BRCA1-target genes [71], also supporting crosstalk
between the DNA damage and spliceosomal machinery. Here, we show that SF3B5 is required
for proper development and cell viability in Drosophila. Notably, our findings indicate that SF3B5 
is required for SAGA-mediated transcriptional activation at a subset of SAGA-regulated genes, 
independent of SAGA’s HAT activity. These observations therefore place SF3B5 in a similar


































































          
        
         
          
          
        
        
          
          
           
           
       
        
        
       
          
             
     
  
    
      
      
        
        
      
           
    
     
          
          
both of SAGA’s histone modifying activities [40]. We cannot exclude the possibility that SF3B5 
is also required for SAGA deubiquitinase activity, since ubH2B levels do not accumulate to
sufficient levels by the larval stage examined. Future studies to examine the requirement of
SF3B5 in ubH2B-deubiquitination will be of interest because ubH2B has been shown to be
important for co-transcriptional splicing. In humans, the ubH2B histone deubiquitinase USP49 is
required for proper splicing of a large number of genes [72]. 
Based on our findings, we conclude that SF3B3 and SF3B5 play dual roles within the cell in 
splicing and in transcription activation by SAGA. There are several precedents for SAGA
subunits that function in other complexes. For example, the HAT component of SAGA, Gcn5, is
shared with the transcription coactivator complex, ATAC [32]. In addition, Sus1 (Drosophila
E(y)2), which is required for SAGA deubiquitinase activity, also functions in RNA export as part
of the TRanscription-Export (TREX) complex [73, 74]. Our findings indicate that similarly to 
these other SAGA subunits that are shared between multiple complexes, SF3B3 and SF3B5
have independent roles in the spliceosome and in SAGA. Despite this independent role, we 
cannot formally exclude the possibility that these subunits mediate transient interactions
between SAGA and the U2 snRNP during co-transcriptional splicing. Further studies to examine 
the SAGA-specific role of SF3B3 and SF3B5 by generating mutations that disrupt the interaction
of these components with SAGA but not the U2 snRNP will be necessary to fully define the role
of these spliceosomal proteins in metazoan SAGA.
Materials and Methods:
Generation of stable cell lines
Drosophila S2 cells were maintained in Hyclone SFX media at 25°C. Stable S2 cell lines 
expressing Spt3 (CG3169, NP_650146), Spt20 (CG17689, NP_648659), SF3B5 (CG11985, 
NP_652189.1) and U2B (sans fille; CG4528, NP_511045.1) in the pRmHa3-CHA2FL2 vector
were generated by co-transfection with pCoBlast (1:10 ratio) using FuGENE HD transfection
reagent (Promega). Selection was carried out in SFX media supplemented with 10% Fetal
Bovine Serum in the presence of 25 - 30 g/mL blastidicin for 2 – 4 weeks.
Affinity purification and MudPIT analysis
Tandem FLAG-HA affinity purification and MudPIT analysis was conducted as described 
previously [40]. Stable S2 cell lines expressing FLAG-HA tagged bait proteins in the pRmHa3-




         
           
                  
          
          
            
           
           
        
        
               
          
         
      
              
         
          
     
           
          
            
          
     
           
           
              
             
          
           
          
     

































extracts were prepared from 4 L of cells grown to a density of 1 x 107 cells/mL. Cells were 
harvested by centrifugation, washed in 10 mM HEPEs [Na+], pH 7.5; 140 mM NaCl, and 
resuspended in 40 mL of Buffer I (15 mM HEPEs [Na+] pH 7.5; 10 mM KCl, 5 mM MgCl2; 0.1
mM EDTA; 0.5 mM EGTA; 350 mM sucrose; supplemented with 20 g/mL leupeptin, 20 g/mL
pepstatin and 100 M PMSF). Nuclei were released by Dounce homogenization (40 strokes
with loose pestle) and pelleted by centrifugation at 10,400 x g for 15 min at 4ºC. Nuclei were 
washed once with Buffer I and then resuspended in 20 mL of Extraction Buffer (20 mM HEPEs 
[Na+], pH 7.5; 10% glycerol; 350 mM NaCl; 1 mM MgCl2; 0.1% TritonX-100; supplemented with 
20 g/mL leupeptin, 20 g/mL pepstatin and 100 M PMSF). Nuclei were incubated in 
Extraction Buffer for 1 h at 4ºC with rotation, and the insoluble chromatin fraction was pelleted 
by sequential centrifugation steps at 18,000 x g 10 min 4ºC and 40,000 rpm 1.5 h 4ºC (50.2Ti
rotor, Beckman). For affinity purification, soluble nuclear extracts were diluted to a final salt
concentration of 150 mM NaCl. Where indicated, 250 g/mL RNAse A was added to soluble 
nuclear extract prior to immunoprecipitation. Nuclear extracts were incubated with 200 L 
(packed bead volume) of anti-FLAG M2 agarose (Sigma) for 4 h – 16 h with rotation, then
washed 3 times in Extraction Buffer containing 150 mM NaCl. FLAG-bound proteins were eluted
4 x with 200 L each of Extraction Buffer (150 mM NaCl) containing 0.5 mg/mL FLAG3 peptide
(3XFLAG: NH2-DYKDDDDKGDYKDDDDKGDYKDDDDK-COOH, synthesized by
Macromolecular Core Facility, Penn State College of Medicine) for 10 min at 25°C. Pooled
FLAG-elutions were incubated with 60 L (packed bead volume) of EZview anti-HA affinity gel
(Sigma) for 4 h – 16 h with rotation, then washed 3 times in Extraction Buffer containing 150 mM
NaCl. HA-bound proteins were eluted 6 x with 150 L each of Extraction Buffer (150 mM NaCl)
containing 0.2 mg/mL HA3 peptide (3XHA: NH2-YPYDVPDYAGYPYDVPDYAGYPYDVPDYA-
COOH, synthesized by Macromolecular Core Facility, Penn State College of Medicine) for 10
min at 25°C. HA-elutions were pooled, and 5 – 10% of the pooled elutions (~200 L) were 
treated with 0.1 U benzonase for 30 min at 37ºC, and then precipitated with 200 L of ice-cold
100 mM Tris-HCl, pH 8.5 and 100 L ice-cold trichloroacetic acid for 16 – 24 h at 4ºC.
Precipitated proteins were collected by centrifugation at > 20,000 x g for 30 min at 4ºC and
washed twice in 1 mL of ice-cold acetone, followed by centrifugation at 20,000 x g for 10 min at
4ºC. The identity and relative abundance of proteins present in the tandem FLAG-HA affinity
purifications was determined using MudPIT [39]. Relative protein levels were estimated using
dNSAFs calculated for each protein as described in [75, 76]. Merged data are shown 
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representing two technical replicates of the MudPIT analysis. Heat maps were generated using
MultiExperiment Viewer (MeV) software.
HAT assays
HAT assays were performed using FLAG-purified SF3B5-complexes and 500 ng HeLa core
histones as substrate as previously described [77]. Each 30 L HAT reaction contains 50 mM
Tris-HCl, pH 8.0, 5% glycerol, 0.1 mM EDTA, pH 8.0, 1 mM DTT, 1 mM PMSF, 0.25 Ci 3H 
Acetyl Coenzyme A (NET290250UC, PerkinElmer), +/- 500 ng HeLa core histones +/- FLAG-
purified SF3B5-complex. Reactions were incubated at 30°C for 30 min and 15 L was spotted
onto P81 phosphocellulose filter paper, washed three times for 5 min each in 50 mM NaHC03 -
NaCO3 buffer, pH 9.2, and rinsed in acetone. Dried P81 filter papers were subjected to 
scintillation counting in 4 mL of ScintiSafe EconoF (FisherChemical). The remaining 15 L of the
HAT reaction was separated by SDS-PAGE (18% gel), stained with Coomassie Brilliant Blue,
incubated with EN3HANCE autoradiography enhancer (PerkinElmer), dried and exposed to X-
ray film for gel fluorography.
Yeast Two-Hybrid
A yeast two-hybrid assay was performed with the Matchmaker Gold Yeast two-hybrid system 
(Clontech). cDNAs were cloned into pGADT7 and pGBKT7 and were validated by sequencing.
For the SF3B3 domain analysis, the Gateway-compatible yeast two-hybrid vectors pGADT7-
GW and pGBKT7-GW were used [78]. Plasmids were transformed into S. cerevisiae Y2Hgold 
and selected for by growth on media lacking leucine and tryptophan. Interaction in the yeast
two-hybrid assay was determined by growth on selective media lacking leucine, tryptophan,
adenine and histidine according to the manufacturer’s instructions.
Genetics
The sf3b5EY12579 1 67c23 CG11985EY12579fly stock, y w ; P59 /TM3, Sb1 Ser1 , was obtained from the
Bloomington Drosophila Stock Center at Indiana University (BL21381). The sf3b5EY12579 mutant
1118was crossed to w ; Drmio/TM3, P{w+mC=GAL4-twi.G}2.3, P{UAS-2xEGFP}AH2.3, Sb1Ser1 
(BL6663) to generate an EGFP balanced stock, which was used to identify homozygous mutant
embryos and larvae as previously described [49]. The SF3B5 cDNA was cloned into the
pUAST-attB vector and transgenic flies were generated using the phiC31 site-specific
integration system in the attP40 site on chromosome 2L [79]. Flies carrying the sf3b5EY12579 
allele on chromosome 3 and either UAS-SF3B5 (w; P{w+mC=UAS-SF3B5}attP40; P{w+mC 
16
 
































































      
       
     
         
  
       
       
       
       
  
          
         
      
       
      
          
         
      
      
        
         
 
  
          
              
        
           
    
        
        
     
+mDint2y =EPgy2}CG11985EY12579/MKRS) or actin5C-GAL4 (w; P{w+mC=Act5C-GAL4}25FO1,
+mDint2P{w+mC=UAS-GFP.nls}14/CyO; P{w+mC y =EPgy2}CG11985EY12579/MKRS) on chromosome
2 were generated using standard genetic techniques. Recombinant flies carrying the
sf3b5EY12579 allele with FRT82B were generated using standard genetic techniques. Mosaic eyes 
1 * consisting of sf3b5EY12579 , ada2b1 or UAS-GFPnls cells were generated by crossing y w ; 
P{w+m*=GAL4-ey.H}3-8, P{w+mC=UAS-FLP1.D}JD1; P{ry+t7.2=neoFRT}82B P{w+mC=GMR-
d2 1118hid}SS4, l(3)CL-R1/TM2 flies with the following genotypes: (1) y w ;; P{ry+t7.2=neoFRT}82B,
+mDint2 , P{ry+t7.2P{w+mC y =EPgy2}CG11985EY12579/TM6b Tb1 , (2) ada2B1 =neoFRT}82B / TM3 Sb1 
1118Ser1 or (3) w ;; P{ry+t7.2=neoFRT}82B P{w+mC=Ubi-GFP(S65T)nls}3R/TM6B, Tb1 . A complete 
description of fly genotypes used in this study is provided in Supplemental Table S2.
Histone Western Blot
Histones were acid-extracted from chromatin prepared from larvae or embryos using a modified
version of the soluble nuclear extraction protocol as described previously [40]. Briefly, nuclei
were isolated as described for affinity purification and MudPIT analysis with two minor
modifications: miracloth was used to filter extracts prior to centrifugation, and buffers were 
supplemented with 10 mM sodium butyrate. Acid-soluble proteins were extracted from the
insoluble chromatin pellet by incubation with 0.4 M HCl for 45 min at 25ºC, concentrated using
trichloroacetic acid precipitation, and analyzed by SDS-PAGE and western blotting using the
following antibodies: anti-histone H2B (Rabbit, 1:1000, Active Motif #39125), anti-acetylated H3 
Lys-9 (Rabbit, 1:2000, Millipore 07-352), anti-Ubiquityl-Histone H2B antibody (1:3000, Millipore 
17-650) and anti-Histone H3 (1:3000. Active Motif 61277). Relative levels of ubH2B/H3 and 
H3K9ac/H2B were quantified using Image Lab Software 5.0 (BioRad) within a single blot or cut
membrane.
qRT-PCR analysis
RNA was isolated using the Zymoprep Direct-zol RNA MicroPrep kit (Zymo Research) and
treated with DNAse I as per the kit protocol. cDNA was generated from 250 ng of RNA using 
Episcript Reverse Transcriptase (Epicentre) using either oligo dTs or random hexamer primers
as indicated. qPCR was conducted using Evagreen 2X Mix (Biotium) and the CFX Connect
Real-time system (Biorad). Quantities were determined relative to a 4-fold dilution series of wild-
type (OregonR) cDNA. Primers against SAGA-regulated genes were taken from previous 
studies [40]. New primers used in this study are as follows: SF3B5 5′-
GCAAAATGGGTGAACGCTAC-3′ and 5′- AGCCACTCGAACTTTGTGGT-3′, Sas10 5′-
17
 


















      
     
         
    
  
        
         
    
ACCGGTGCTCAACTACGTTC-3′ and 5′- GCTCCTCGATCAGATCCTTG-3′, Oda (unspliced) 5’-
CCGTGCAAAAAGTGAATGTG-3’ and 5’- GCCAACCTGGAGAACGTCTA -3’, Sap47 (unspliced)
5’-ATCGATATTCCGCTTGTTGC-3’ and 5’- GCGCAAGTTTGATATTGTCG-3’, exba (unspliced)
5’- GAGCCCAAGGACAGGATTG-3’ and 5’- TGCTTGAACGTCTGGAACAG-3’, Crc (unspliced) 5’-
CGGACGAGTTGTCAACAGAA-3’ and 5’- TCTGAAGATGCACCGAATTG-3’.
Accession Numbers
The complete MudPIT dataset (raw files, peak files, search files, as well as DTASelect result
files) can be obtained from the MassIVE database via ftp://massive.ucsd.edu/ using the





































































           
      
        
          
         
       
      
             
     
      
         
          
           
        
       
          
         
         
     
             
       
         
           
          
           
           
         
         
         
       
       
          
Figure Legends:
Fig 1. SF3B3 and SF3B5 are novel components of Drosophila SAGA. (a) Heat map
showing the relative spectral abundance of SAGA and spliceosomal subunits expressed as 
dNSAF (distributive normalized spectral abundance factor) in tandem FLAG-HA purifications
from S2 cells using U2B, SF3B5, Ada2B-PB, Spt3, Spt20, ATXN7, Ada1, SAF6, Sgf29 and 
WDA as bait proteins, relative to control purifications from untagged S2 cells (S2 -) or S2 cells 
expressing non-specific tagged protein CG6459. Bait proteins were C-terminally tagged as 
indicated (C). Bait proteins new to this study are highlighted in red. The dNSAF scale is shown 
at the top of panel (a) with the highest abundance subunits represented in yellow, and absent or
under-represented subunits in blue. dNSAF values used to generate the heat map are provided 
in Supplemental Table S1. (b, c) The HAT activity of FLAG-purified SF3B5-complexes was 
assayed in vitro by incorporation of 3H-acetyl CoA into core histones. Core histones and/or
FLAG-purified SF3B5-complex were included in each HAT assay as indicated by +/- below the
graph in panel b, and 3H-acetyl CoA incorporation assayed for each reaction using both 
scintillation counting (b) and fluorography (c). Lanes in panel (c) correspond to reactions from
above (panel b). Reactions containing complex and histones were performed in triplicate and 
compared to background levels of single control reactions lacking histones or complex as part of
the set of HAT assays previously described for WDA- and SAF6-purified SAGA [40]. Error bars 
in panel (b) for + SF3B5-complex + histones represent standard deviation of the mean for three
technical replicates. (c) Histones were separated by SDS-PAGE, stained with Coomassie 
Brilliant Blue (CBB) to determine the migration of each histone (upper panel), and 3H-acetyl CoA
incorporation for each histone examined using fluorography (FL).
Fig 2. SF3B3 and SF3B5 bind SAGA independent of RNA. (a, b) SAGA was FLAG-HA 
purified from S2 cells using WDA as bait protein following treatment of the soluble nuclear
extract with RNAse A. An ethidium bromide stained agarose gel of the soluble nuclear extract
(NE, 10 µL, + and 20 µL, ++) used for immunoprecipitation with and without RNAse treatment
(+/- respectively) is shown in panel (a), and a silver stained SDS-PAGE gel of the purified WDA-
complexes +/- RNAse treatment is shown in panel (b). (c) Peptides from SF3B3 and SF3B5 are 
identified at similar levels in SAGA purifications from S2 cells using WDA as bait in the presence 
and absence of RNAse treatment. Sequence coverage (%) and number of peptides (spectral
count) are shown for each polypeptide, relative to the bait protein WDA.
Fig. 3 SF3B3 and SF3B5 interact with Sgf29 and Spt7 by yeast two-hybrid analysis. (a) 
Yeast two-hybrid assay was performed to test the interaction of SAGA subunits fused to the
19
 


































































           
           
         
      
       
            
         
          
            
           
          
           
         
          
       
          
             
        
            
          
         
            
            
            
         
         
      
         
        
    
      
        
Gal4 activating domain (AD) with SF3B3 or SF3B5 fused to the Gal4 DNA binding domain 
(DBD). Empty plasmids containing only the activating domain (AD, left column) or DNA binding
domain (DBD, top row) were used to test for auto-activation of each protein. Approximately
30,000 cells were spotted on media lacking leucine, tryptophan, adenine and histidine for each 
tested interaction between AD- and DBD-fusion proteins (boxes). Images are shown for
representative spots for each tested interaction (black boxes) indicating growth or no growth. 
ND, not determined. (b) Protein alignment of SF3B3 in S. cerevisiae (Rse1), D. melanogaster
and H. sapiens. Motifs were identified using Pfam and are shown in grey boxes with the length 
of each domain indicated in parenthesis and percentage similarity for domains between species
shown flanked by dotted lines. The numbers above the proteins denote the amino acids in the
sequence showing placement of the domains. Overall percent sequence similarity for each full-
length protein pair is shown to the right of the schematic. (c) Yeast two-hybrid assay was 
performed as described in panel a. Plasmids used in this panel are gateway compatible vectors
denoted “GW”. SF3B3-FL contains the full length SF3B3 construct, SF3B3-N contains amino
acids 1 - 746 and SF3B3 contains amino acids 747 - 1227 in the pGBKT7-GW plasmid.
Fig 4. SF3B5 is necessary for organismal and cell viability. (a) Schematic representation of
the SF3B5 (CG11985) locus on chromosome 3R showing the position of the P-transposon
EY12579. The single exon of the SF3B5 gene is represented by the grey box. Translated
sequences are filled with grey, and 5' and 3' untranslated regions are shown as open boxes. 
The +1 position corresponds to the ATG of the translation start site. (b) Genetic crosses were 
conducted with flies carrying the UAS-SF3B5 rescue construct or the actin5C-GAL4 driver on
chromosome 2, and the sf3b5EY12579 allele on chromosome 3. Surviving adult progeny were 
scored for the presence of the balancer chromosomes using the curly wing phenotype (CyO)
and the bristle marker stubble (MKRS). The number of surviving adult progeny and the total
number of flies scored are shown for each genotype. (c) Mutant fly eyes were generated using
the GMR-hid technique with the following genotypes, Ubi-nlsGFP (wild type), ada2b and
sf3b5EY12579 . A representative image from a single male fly of each indicated genotype is shown. 
(d) Mean eye widths of mutant fly eyes generated as described in panel (c) were determined for 
each indicated genotype. The widths of four separate fly eyes from four independent animals
(one eye per animal) were measured, and standard deviation is indicated by error bars. Full
genotypes of flies are shown in Supplemental Table S2.
Fig 5. SF3B5 is necessary for expression of a subset of SAGA-regulated genes


























































         
        
        
     
           
           
           
          
         
         
         
            
        
              




        
          
           
       
        
         
            
           
1118 , WT), nonstop and sf3b5EY12579 (OregonR or w first instar larvae (L1), OregonR and wda
embryos, and OregonR and sgf11 third instar larvae (L3) were analyzed by SDS-PAGE and 
western blotting using antibodies against H3K9ac and H2B, or ubH2B and H3. (b) RNA was 
isolated from OregonR (wild-type), sf3b5EY12579 and wda 18 - 24 h embryos and qRT-PCR was 
performed on oligodT-reverse transcribed cDNA. Mean expression levels are normalized to 
RpL32 and shown relative to OregonR, which is set as 100%. Error bars denote standard error
of the quotient for four biological experiments, and p-values for each comparison determined 
using ANOVA and Tukey’s honest significant difference (HSD) test are shown in Supplemental
Table S3. (c) qRT-PCR was performed as described in panel (b) with random hexamer-reverse
transcribed cDNA and primers designed to amplify exon/intron junctions to detect unspliced
transcripts. Mean expression levels of the ratio of unspliced to spliced transcripts are normalized
to RpL32, and shown relative to OregonR, which is set as 100%. Error bars denote standard
error of the quotient for four biological experiments, and p-values for each comparison are
shown in Supplemental Table S3. (d) qRT-PCR was performed on OregonR and sf3b5 first
instar larvae as described for panel (b). Error bars denote standard error of the quotient for
three biological experiments, and p-values for each comparison are shown in Supplemental
Table S3.
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 number  Protein
  Bait: % (spectral count)
Length 
 (aa)U2B  SF3B5 Spt3  Spt20
 FBgn0050390  CG30390  Sgf29  X  25.95%(10)  59.52%(74)  57.44%(97)  289
 FBgn0030891  CG7098  Ada3  X  10.97%(13)  34.53%(59)  32.91%(101)  556
 FBgn0020388  CG4107  Gcn5  X  17.34%(31)  39.98%(162)  51.91%(253)  813
 FBgn0037555  CG9638  Ada2b-PB  X  16.94%(27)  42.88%(91)  44.14%(174)  555
 FBgn0051866  CG31866  Ada1  X  12.66%(8)  39.94%(60)  40.26%(73)  308
 FBgn0031281  CG3883  SAF6  X  17.85%(45)  33.33%(123)  42.4%(153)  717
 FBgn0036374  CG17689  Spt20  X  8.6%(25)  25.2%(385)  36.04%(1423)  1873
 FBgn0037981  CG3169  Spt3  X  15.1%(17)  42.19%(693)  26.56%(149)  384
 FBgn0030874  CG6506  Spt7  X  24.23%(32)  33.43%(210)  36.77%(186)  359
 FBgn0026324  CG3069  TAF10b  X  23.29%(4)  23.29%(16)  18.49%(5)  146
 FBgn0011290  CG17358  TAF12  X  5.63%(1)  36.25%(18)  36.25%(25)  160
 FBgn0000617  CG6474  TAF9  3.96%(1)  32.73%(18)  33.09%(72)  36.69%(74)  278
 FBgn0053554  CG33554  Tra1 (Nipped-A)  X  16.15%(117)  28.02%(344)  45.33%(1364)  3790
 FBgn0039067  CG4448  WDA  X  24.5%(43)  47.51%(240)  48.86%(373)  743
 FBgn0031420  CG9866 ATXN7  X  2.47%(5)  18.02%(46)  33.88%(108)  971
 FBgn0000618  CG15191  E(y)2  X  34.65%(13)  42.57%(25)  51.49%(26)  101
 FBgn0013717  CG4166  Nonstop  X  4.84%(7)  23.76%(64)  28.59%(148)  703
 FBgn0036804  CG13379  Sgf11  X  8.67%(4)  44.9%(73)  44.9%(139)  196
 FBgn0040534  CG11985  SF3B5  83.53%(46)  67.06%(89)  67.06%(33)  83.53%(32)  85
 FBgn0035162  CG13900  SF3B3  54.12%(629)  58.92%(2997)  51.83%(639)  51.02%(715)  1227
 FBgn0031493  CG3605  SF3B2 (SF3b145)
 SF3B4
 37.12%(146)  47.4%(123)  X  X  749
 FBgn0015818  CG3780  (SF3b149/Spx)  28.24%(353)  23.63%(410)  X  X  347
 FBgn0035692  CG13298  SF3B6 (SF3b14a)  49.59%(92)  55.37%(201)  X  X  121
 FBgn0031822  CG9548  PHF5A (SF3b14b)  33.33%(8)  7.21%(1)  X  X  111
 FBgn0031266  CG2807  SF3B1 (SF3b155)  52.76%(557)  54.93%(1200)  X  X  1340
 FBgn0266917  CG16941  SF3A1 (SF3a120)  52.42%(313)  49.74%(340)  X  X  784
 FBgn0014366  CG2925  SF3A3 (SF3a60/noi)  54.27%(337)  56.26%(281)  X  X  503
 FBgn0036314  CG10754  SF3A2 (SF3a66)  46.21%(120)  34.47%(222)  X  X  264
 FBgn0262601  CG5352  SmB  49.25%(354)  29.65%(37)  7.04%(2)  10.55%(1)  199
 FBgn0261933  CG10753  SmD1 (snRNP69D)  52.42%(576)  35.48%(56)  16.13%(5)  16.13%(2)  124
 FBgn0261789  CG1249  SmD2  56.3%(323)  47.9%(39)  X  X  119
 FBgn0023167  CG8427  SmD3  35.76%(773)  6.62%(7)  X  X  151
 FBgn0261790  CG18591  SmE  71.28%(524)  67.02%(51)  15.96%(1)  X  94
 FBgn0000426  CG16792  SmF (DebB)  48.86%(45)  39.77%(13)  X  X  88
 FBgn0261791  CG9742  SmG  57.89%(196)  28.95%(9)  X  X  76
 FBgn0033210  CG1406  U2A  61.89%(320)  57.74%(114)  23.02%(5)  X  265










         
       
Table 1. Sequence coverage (%) and number of peptides (spectral count) for each
polypeptide identified in MudPIT analysis of affinity purifications using U2B, SF3B5, Spt3
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Abstract:
The interaction between splicing factors and the transcriptional machinery provides an intriguing
link between the coupled processes of transcription and splicing. Here, we show that two 
components of the SF3B complex that forms part of the U2 small nuclear ribonucleoprotein 
particle (snRNP), SF3B3 and SF3B5, are also subunits of the Spt-Ada-Gcn5 acetyltransferase
(SAGA) transcriptional coactivator complex in Drosophila melanogaster. Whereas SF3B3 had
previously been identified as a human SAGA subunit, SF3B5 had not been identified as a 
component of SAGA in any species. We show that SF3B3 and SF3B5 bind to SAGA
independent of RNA, and interact with multiple SAGA subunits including Sgf29 and Spt7 in a 
yeast two-hybrid assay. Through analysis of sf3b5 mutant flies, we show that SF3B5 is
necessary for proper development and cell viability, but not for histone acetylation. Although 
SF3B5 does not appear to function in SAGA’s histone modifying activities, SF3B5 is still
required for expression of a subset of SAGA-regulated genes independent of splicing. Thus, our
data support an independent function of SF3B5 in SAGA’s transcription coactivator activity that
is separate from its role in splicing.
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36 H3K9ac, acetylated histone H3 Lysine 9; GFP, green fluorescent protein; HAT, histone
37 acetyltransferase; ubH2B, monoubiquitinated histone H2B; MudPIT, Multidimensional Protein 
38 Identification Technology; qRT-PCR, quantitative reverse transcription polymerase chain 




43 Splicing occurs co-transcriptionally and is affected by transcription rate, chromatin modifications,
44 and nucleosome occupancy [1-8]. Emerging evidence suggests that components involved in 
splicing can also modulate transcription [9-11]. Moreover, several splicing factors have been
46 shown to interact with chromatin remodelers [12], histone marks [13-16], or RNA polymerase II
47 itself [17], indicating that there are multiple mechanisms that couple transcription to splicing.
48
49 One intriguing link between splicing and transcription is provided by components that are
present both in the spliceosome machinery and in transcriptional regulators. For example, a
51 major component of the spliceosome, the U1 snRNA, interacts with the general transcription 
52 initiation factor TFIIH to stimulate transcription initiation [10]. In addition, the U2 small nuclear
53 ribonucleoprotein particle (snRNP) interacts with the transcription elongation factor TAT-SF1,
54 and extracts depleted for U2 snRNP show a decrease in transcriptional activity [11]. Further, the
SF3B3 (Splicing Factor 3b, subunit 3) subunit of the SF3B complex within the U2 snRNP
56 associates with the transcription factors ERG and TFIIS [18, 19]. Strikingly, SF3B3 is also a
57 subunit of the mammalian Spt-Ada-Gcn5-acetyltransferase (SAGA) transcriptional co-activator
58 complex [20, 21]. Thus, SF3B3 functions as a shared subunit of the U2 snRNP and SAGA.
59 SF3B3 is highly conserved from yeast to humans, and its homolog in Saccharomyces 
cerevisiae, Rse1, is an essential gene that is necessary for proper splicing [22-25]. SF3B3 
61 functions as part of the SF3B complex that contributes to recognition of the intron branch site in 
62 the pre-mRNA by the U2 snRNP during the first step of splicing [26-29]. Whereas the SF3B
63 complex itself plays a well-defined role in the first step of splicing, the function of its SF3B3
64 subunit that is shared with SAGA, either in splicing or in transcription, has not been well defined. 
Here, we report the identification of a second SF3B component, SF3B5 (Splicing Factor 3b,




































































         
            
        
           
            
         
        
           
           
      
          
          
  
           
           
              
            
         
         
    
           
           
         
             
         
              
       
      
            
          
          







67 independent SF3B subunits are components of metazoan SAGA, we sought to determine the
68 function of these shared SF3B subunits in SAGA. SAGA is highly conserved from yeast to 
69 humans and possesses several distinct activities that regulate different aspects of transcription
activation [30]. First, SAGA contains the histone acetyltransferase Gcn5 that acetylates histone
71 H3 [31]. Gcn5 is also found in a second transcriptional coactivator complex in flies and humans,
72 the Ada2a-containing complex (ATAC) that is distinct from SAGA [32]. Second, SAGA contains 
73 a histone deubiquitinase, Ubp8 (Nonstop in Drosophila), that deubiquitinates monoubiquitinated
74 histone H2B (ubH2B) [33]. Independent of these histone modifying activities, SAGA is also a 
direct coactivator that recruits RNA polymerase II to promoters [34, 35]. Although SAGA is best
76 characterized with regard to its roles at promoters, SAGA also co-localizes with RNA 
77 polymerase II on transcribed regions [36-38]. Thus, SAGA and the SF3B complex share a
78 common spatial and temporal distribution during the coupled processes of transcription and
79 splicing.
In this study, we examine the function of the shared SAGA/U2 snRNP subunit, SF3B5, in 
81 SAGA-regulated histone modification and gene expression. We show that SF3B5 is required for
82 expression of a subset of SAGA-regulated genes, including a gene that contains no introns in its
83 coding region, but is not required for SAGA-mediated histone acetylation. Thus, our findings are
84 consistent with a function for SF3B5 in SAGA-dependent transcription but not histone
modification, independent of its function in the U2 snRNP.
86 Results and Discussion:
87 Identification of two SF3B proteins within the Drosophila SAGA complex
88 To identify novel Drosophila SAGA subunits, we isolated SAGA using tandem FLAG-HA affinity
89 purification from S2 cell nuclear extracts with the SAGA-specific subunits Spt3 and Spt20 as 
bait proteins and examined the composition of affinity purified SAGA by Multidimensional
91 Protein Identification Technology (MudPIT) [39]. Purifications using the SAGA-specific subunits
92 Ada2b (isoform PB), ATXN7, Ada1, SAF6, WDA and the shared ATAC/SAGA subunit Sgf29 as
93 bait proteins were previously described and are shown for comparison [40, 41]. Peptides from
94 two proteins were consistently identified in affinity-purified SAGA: CG11985 and CG13900. 
These two proteins correspond to components of the U2 snRNP spliceosomal complex: SF3B3
96 (Splicing Factor 3b subunit 3, GeneID: CG13900; FlyBase ID: FBgn0035162) and SF3B5 
97 (Splicing Factor 3b subunit 5, GeneID: CG11985; FlyBase ID: FBgn0040534) (Fig. 1a, Table 1) 





































































































































        
     
          
           
          
          
      
        
           
        
          
   
           
        
       
          
         
        
          
  
        
            
          
       
             
         
           
             
              
         
             
abundance factor) levels to those of the core SAGA subunits Spt7 and TAF9, and were not
identified in control purifications from cells expressing a non-specific tagged bait protein, or in 
samples from cells lacking tagged protein (Fig. 1a, Supplemental Table S1).
To determine whether these splicing proteins were indeed SAGA subunits, we purified tagged
SF3B5 from S2 cell nuclear extract and analyzed the resulting complexes by MudPIT. FLAG-HA 
tandem affinity chromatography of SF3B5 co-purifies all of the known subunits of both the
SAGA and the U2 snRNP complexes (Fig. 1a, Table 1, SF3B5 bait column). Although MudPIT 
analysis of purified SF3B5 identifies all known SAGA subunits, TAF12 is significantly under-
represented and was identified in only one of the two technical replicate MudPIT analyses. It is 
unclear whether this is due to interference of the FLAG-HA epitope tag on SF3B5 with the
binding of TAF12 to SAGA, or if SF3B5-SAGA complexes indeed contain reduced levels of
TAF12. Despite this, our observations indicate that SF3B3 and SF3B5 are bona fide subunits of
both SAGA and the U2 snRNP.
SF3B3 had previously been identified as a component of the mammalian SAGA complex [20,
21], but SF3B5 represents a novel subunit of SAGA. Additionally, both SF3B3 and SF3B5 were 
identified as interacting with mammalian Sgf29 (CCDC101) [44], which is a shared subunit of
the Gcn5-containing SAGA and ATAC complexes [30]. Thus, these data collectively support
that both SF3B3 and SF3B5 are subunits of metazoan SAGA. Notably, neither SF3B3 (Rse1)
nor SF3B5 (Ysf3) associate at detectable levels with TAP-purified SAGA or SLIK in S.
cerevisiae [45]. Thus, the presence of spliceosomal proteins within SAGA appears to be unique
to higher eukaryotes.
SF3B3 and SF3B5 are independent subunits of SAGA and the U2 snRNP
Since SF3B3 and SF3B5 are known components of the SF3B complex within the larger U2
snRNP spliceosomal machinery [46, 47], we next asked whether SAGA and other U2 snRNP
subunits were physically associated. To do this, we examined the SAGA-specific purifications 
for the presence of other SF3B proteins, SF3A complex subunits, Sm proteins, or the U2B
protein itself. Additional components of the U2 snRNP were not identified reproducibly in 
purifications using the SAGA-specific subunits Ada2B (isoform PB), Spt3, Spt20, ATXN7, Ada1,
SAF6 or WDA (Fig. 1a, Supplemental Table S1). This indicates that the majority of SAGA does
not stably associate with other subunits of the SF3B complex or the larger U2 snRNP under the
conditions used for our purifications. However, affinity purifications of the shared ATAC and




































































































































          
       
         
             
          
             
          
         
        
 
    
        
         
        
           
     
            
             
          
             
             
          
        
      
        
         
      
        
          
               
          
snRNP (Fig. 1a, Supplemental Table S1). This suggests that there is potential cross-talk 
between the U2 snRNP and a subset of SAGA complexes involving Sgf29. It is unlikely that this 
represents an interaction between the U2 snRNP and the alternative Gcn5-containing complex,
ATAC, because SF3B3 and SF3B5 are not detected in purifications using ATAC-specific
subunits as bait [48]. Further, when we purify the U2 snRNP using U2B as bait protein, we only
identify proteins from the U2 snRNP spliceosomal complex including SF3B and SF3A complex
subunits (Fig. 1a, Table 1). Although one peptide for TAF9 is identified in the U2B purification,
we do not identify peptides from any other SAGA subunits including Sgf29 (Table 1). Thus,
SF3B3 and SF3B5 are independently associated with SAGA and the U2 snRNP, and do not
mediate a stable interaction between these two complexes under the conditions used for our
purifications.
SF3B5-containing SAGA complexes acetylate histones
We next asked whether SF3B5-purified SAGA complexes had histone acetyltransferase (HAT) 
activity. To do this, we performed HAT assays using SF3B5-purified SAGA complex on HeLa 
core histones as substrate. SF3B5-purified SAGA demonstrated HAT activity on core histones 
(Fig. 1b), predominantly on histone H3 and to a lesser extent on histone H4 (Fig. 1c). This HAT 
activity shows a similar histone preference to SAGA purified through SAGA-specific subunits 
such as SAF6 or WDA [40, 49]. Since the SF3B5-complex HAT assays were performed as part
of the same set of HAT assays described in Weake et al. (2009) for WDA and SAF6-purified
SAGA, we can compare the HAT activity of these SAGA complexes on histones [40]. Notably,
the level of HAT activity of SF3B5-purified SAGA is 2 – 3 fold lower than that of SAGA purified
using the core SAGA subunits WDA or SAF6 as bait proteins. However, the SF3B5-purified
complex also contains much lower levels of Gcn5 relative to WDA or SAF6-purified SAGA
because SF3B5 also co-purifies components of the U2 snRNP in addition to SAGA (compare
dNSAF values for Gcn5 in each purification in Supplemental Table S1). Our data therefore
indicate that SF3B5-containing SAGA complexes contain the full complement of SAGA subunits 
and are capable of acetylating histones in a SAGA-specific pattern, suggesting that these
complexes purified through SF3B5 represent functional SAGA complexes.
The association of SF3B3 and SF3B5 with SAGA does not require RNA
Next, we sought to determine if the association of SF3B3 and SF3B5 with SAGA requires the
presence of RNA since the U2 snRNA is a core component of the U2 snRNP [50]. To do this,







































































































































         
         
         
           
       
              
         
        
          
          
      
      
         
            
        
       
             
         
              
           
           
        
       
        
              
        
             
            
        
         
      
           
(RNAse) using tandem FLAG-HA affinity chromatography against the bait protein WDA. RNAse
treatment reduces nucleic acids in the soluble nuclear extract to levels that are not detectable
by ethidium bromide staining following agarose gel electrophoresis (Fig. 2a). However, the
composition of SAGA purified via WDA from nuclear extract treated with RNAse appears 
identical to SAGA purified in the absence of RNAse by SDS-PAGE and silver staining (Fig. 2b). 
To examine whether SF3B3 and SF3B5 remained present in SAGA following RNAse treatment,
we examined the composition of SAGA purified in the presence of RNAse by MudPIT analysis.
Notably, similar levels of peptides as determined by spectral counts for SF3B3 and SF3B5 are 
observed in the SAGA purifications from nuclear extract treated with RNAse relative to the
untreated nuclear extract (Fig. 2c). Thus, the association of SF3B3 and SF3B5 with SAGA does 
not require RNA. This finding is consistent with the lack of annotated RNA-interacting domains
in SF3B3 and SF3B5, and with observations that suggest that SF3B3 and SF3B5 are not
directly involved in pre-mRNA branch-point recognition [28].
SF3B3 and SF3B5 interact with Sgf29 and Spt7 in SAGA
Since the incorporation of SF3B3 and SF3B5 within SAGA is independent of RNA, we next
sought to identify the protein subunits in SAGA that interacted with these spliceosomal proteins. 
We hypothesized that SF3B3 and SF3B5 would interact with SAGA-specific subunits, since
these proteins are not found in the related ATAC complex [48]. To test the pair-wise interaction
between SF3B3, SF3B5 and each SAGA subunit, we performed a yeast two-hybrid assay with
17 of the characterized Drosophila SAGA subunits as prey, and either SF3B3 or SF3B5 as bait.
We did not analyze the SAGA subunit Tra1 (NippedA), which is also a component of the
Drosophila Tip60 complex [51], in this assay due to the large size of its coding sequence and
high probability of auto-activation. When we examined the pair-wise interaction of SF3B3 and
SF3B5 by yeast two-hybrid analysis, we observed a strong reciprocal interaction between 
SF3B3 and SF3B5 (Fig. 3a). Importantly, neither SF3B3 nor SF3B5 auto-activate transcription
of the reporter genes since co-expression of either SF3B3 or SF3B5 fused to the Gal4 DNA-
binding domain (DBD) with the plasmid encoding the Gal4 Activating Domain (AD) alone does 
not result in growth on selective media (Fig. 3a, left column). We next examined the interaction
of SF3B3 and SF3B5 with the 17 SAGA subunits. The SAGA subunits assayed also do not
auto-activate reporter gene transcription because co-expression of SAGA subunits fused to the
AD with the plasmid encoding the DBD alone does not result in growth on selective media (Fig. 
3a, top row). Interestingly, we observed interactions between SF3B5 and several proteins within 






































































































































         
        
       
        
          
             
           
        
            
         
       
          
       
          
         
        
          
     
         
      
        
         
      
        
       
        
          
           
   
          
         
         
between SF3B3 and SAGA subunits, with only Sgf29, Spt7, and WDA showing growth on 
selective media (Fig. 3a). The binding of Spt20 to SF3B3 was unable to be determined because 
we did not observe a consistent growth phenotype. Since Sgf29 and Spt7 were identified as 
interacting with both SF3B3 and SF3B5, these proteins provide the most likely candidates for
SAGA subunits that mediate the incorporation of these two spliceosomal subunits into the
SAGA complex. This finding is not consistent with our hypothesis since Sgf29 is also a subunit
of the Gcn5-containing ATAC complex. Because the yeast two-hybrid assay tests binding of
proteins in vivo, we cannot exclude the possibility that the interaction between Drosophila SAGA
subunits and SF3B3 or SF3B5 is mediated by endogenous yeast proteins. Despite this caveat, 
the results from this yeast two-hybrid assay indicate that Sgf29 and Spt7, potentially in 
conjunction with some of the HAT module subunits and core components Spt3, Spt20 and
WDA, provide a binding surface for SF3B3 and SF3B5 within Drosophila SAGA.
The interaction of SF3B3 with Sgf29 and Spt7 is mediated by different domains
Since the association of SF3B3 and SF3B5 with SAGA is observed in Drosophila and humans,
but not in S. cerevisiae, we wondered whether there were differences in the yeast and
metazoan versions of these proteins that might account for this differential interaction. To 
examine this possibility, we first compared yeast, Drosophila and human SF3B5 using BLAST 
[52]. Yeast Ysf3 shares 53% sequence similarity with Drosophila SF3B5 and 50% sequence
similarity with human SF3B5, while Drosophila and human SF3B5 share 91% sequence
similarity. Additionally, there are no identifiable domains in any of the SF3B5 orthologs. Next, we 
compared yeast, Drosophila and human SF3B3. While Drosophila and human SF3B3 share
86% sequence similarity, yeast Rse1 shares 42% sequence similarity with Drosophila SF3B3. 
However, the N-terminal region of Drosophila and human SF3B3 contains a domain that is 
absent in yeast: the Mono-functional DNA-alkylating methyl methanesulfonate (MMS1) domain 
(Fig. 3b). The MMS1 domain is found in proteins that protect against replication-dependent DNA 
damage [53]. A second domain, the cleavage and polyadenylation specificity factor (CPSF) 
domain, whose namesake is necessary for proper 3’ end processing and pre-mRNA splicing
[54], is conserved in all three species (Fig. 3b). Since the MMS1 domain of Drosophila and 
human SF3B3 is not present in yeast SF3B3, we hypothesized that this domain is required for
binding of SF3B3 to SAGA in Drosophila. 
To test if the N-terminal region of Drosophila SF3B3 that contains the MMS1 domain was 
necessary for its binding within SAGA, we repeated our yeast two-hybrid analysis with the N-







































































































































          
        
    
        
               
      
        
         
           
        
      
         
              
      
      
            
             
          
            
           
           
         
   
             
         
          
         
        
       
             
        
            
proteins. The bait proteins used in this assay consist of full length SF3B3 (SF3B3-FL), the N-
terminal domain of SF3B3 (SF3B3-N, aa1 - 746) and the C-terminal domain of SF3B3 (SF3B3-
C, aa747 – 1227). Consistent with our previous yeast two-hybrid analysis, we observe growth 
on selective media when SF3B5, Sgf29 or Spt7 are co-expressed with full-length SF3B3.
However, surprisingly we did not observe an interaction between SF3B5 and either the SF3B3 
N- or C-terminal regions (Fig. 3c), indicating that neither of these domains are sufficient for this
interaction. This lack of interaction is unlikely to be due to expression problems, since we 
observe interactions between the SF3B3 C-terminal domain (SF3B3-C) and Spt7, and the
SF3B3 N-terminal domain (SF3B3-N) and Sgf29 respectively. Thus, in the yeast two-hybrid
assay, the C-terminal region of SF3B3 that contains the conserved CPSF domain is sufficient to
interact with Spt7, whereas the N-terminal region of SF3B3 that contains the metazoan-specific 
MMS1 domain is sufficient to interact with Sgf29. This unexpected result indicates that the
presence of the MMS1 domain in metazoan SF3B3 is not sufficient to account for the presence 
of SF3B3 in Drosophila SAGA but not yeast SAGA. Thus, both the N- and C-terminal regions of
SF3B3 contribute to its association with SAGA through independent binding to Spt7 and Sgf29.
SF3B5 is necessary for proper development and cell viability
Whereas SAGA is not essential for viability in S. cerevisiae, mutations that disrupt SAGA in 
Drosophila are lethal during the larval or early pupal stages of development [40, 41, 49, 55-59]. 
To determine if SF3B5 was also required for development, we sought to identify a loss of
function mutation in the SF3B5 gene. We identified a P-element insertion in the coding region of
the intronless SF3B5 gene, EY12579 [60] (Fig. 4a). We were only able to identify flies carrying
the balancer chromosome in this stock, suggesting that this insertion is homozygous lethal. We
will hereafter refer to flies carrying this EY12579 transposon insertion as sf3b5EY12579 mutant
flies (Supplemental Table S2).
To determine if the lethality in the sf3b5EY12579 flies resulted from loss of SF3B5 function, we 
generated transgenic flies that express wild-type SF3B5 under GAL4/UAS regulatory control
(UAS-SF3B5) [61]. We then crossed flies carrying the sf3b5EY12579 allele and the UAS-SF3B5
transgene with sf3b5EY12579 flies that also ubiquitously express GAL4 under control of the
Actin5C promoter as outlined in Figure 4b. Since the UAS-SF3B5 transgene and actin5C-GAL4
driver are on chromosome 2, and the sf3b5EY12579 allele is on chromosome 3, there are four
different potential phenotypes in the resulting progeny from this cross: Half of the progeny will
have the actin5C-Gal4 driver on chromosome 2 and will therefore express UAS-SF3B5







































































































































        
         
          
           
             
          
             
          
            
           
       
          
           
       
           
          
        
      
        
           
            
 
           
           
            
           
        
           
        
        
            
       
UAS-SF3B5. In each of these halves of the resulting progeny, flies will also either be
homozygous or heterozygous for the sf3b5EY12579 allele on chromosome 3, which can be
distinguished by the presence of the stubble marker on the MKRS balancer chromosome. As
expected since the sf3b5EY12579 allele is homozygous lethal, 100% of CyO progeny from this 
cross contained the stubble marker, indicating presence of the balancer chromosome (Fig. 4b).
If expression of the UAS-SF3B5 transgene is sufficient to rescue viability of the sf3b5EY12579 
mutant, then we would expect to see adult progeny that lack the stubble marker only in those 
flies that also lack the CyO balancer chromosome, as determined by the curly wing marker.
When we examined the flies that lacked the CyO balancer chromosome, we found that 9% of
flies without the CyO balancer also lacked the stubble marker, indicating that expression of
SF3B5 rescues lethality of the sf3b5EY12579 allele (Fig. 4b). Thus we conclude that the lethality
associated with the sf3b5EY12579 allele is due to loss of function of SF3B5.
Mutations in other SAGA subunits result in lethality in different stages of larval development,
most probably due to residual maternal load of mRNAs for these subunits. For example, ada2b
and nonstop homozygotes die as pupae, gcn5 homozygotes die as third instar larvae, and saf6
and wda homozygotes die as second instar larvae [40, 49, 57, 62, 63]. To compare sf3b5EY12579 
flies with other SAGA mutants, we sought to determine the developmental stage at which 
homozygous sf3b5EY12579 flies die. To do this, we generated flies that carried the sf3b5EY12579 
allele over a balancer chromosome marked with the green fluorescent protein (GFP). We then
identified homozygous sf3b5EY12579 embryos by lack of GFP expression. We observed growth of
homozygous sf3b5EY12579 embryos until the first instar larval stage, but we did not observe any
further growth, indicating that loss of SF3B5 results in lethality at the first instar larval stage of
development. 
Since SF3B5 is necessary for viability on an organismal level, we next wanted to determine if
SF3B5 is also necessary for cell viability. In yeast, YSF3 is an essential gene for growth, 
suggesting that the function of SF3B5 in splicing plays a critical role for cell survival [24, 25]. To 
test whether SF3B5 is necessary for cell viability in Drosophila, we generated mosaic flies that
are heterozygous for sf3b5EY12579 in all tissues except the eyes, in which the cells are
homozygous for the sf3b5EY12579 allele [64]. Using this approach, we would expect to observe full
or partial eye ablation in flies carrying homozygous sf3b5EY12579 cells in the eye if SF3B5 is 
necessary for cell viability or cell division. As a control, we generated eyes carrying two copies 
of a non-essential transgene, GFP, on an otherwise wild-type chromosome. The eyes of these

























































































































































































        
          
         
            
         
     
          
         
         
            
           
           
         
   
          
           
        
           
      
          
        
       
      
          
     
            
       
             
          
       
  
sf3b5EY12579 showed dramatic eye ablation (Fig. 4c). To quantify this eye ablation, we measured
the width of these eyes in each genotype (n = 4) and found that sf3b5EY12579 eyes were 
approximately four-fold smaller than those of the wild-type (GFP) control (Fig. 4d). Since these
results indicate that SF3B5 is likely to be required for cell viability, we next asked if SAGA
subunits were also required for cell viability. To do this, we generated mosaic flies using the
same approach that contain eyes homozygous for a mutation in Ada2B. Ada2b is a SAGA-
specific subunit that interacts with Gcn5 and is necessary for H3 acetyltransferase activity by
SAGA [62, 65]. In contrast to sf3b5EY12579 , ada2b eyes are similar in size to the GFP control (Fig. 
4c, d). Similar results were observed for nonstop mutations that disrupt the deubiquitinase
activity of SAGA (data not shown). Thus, we conclude that SF3B5, but not other SAGA
subunits, is required for cell viability. This finding is consistent with the essential role of SF3B3 
(Rse1) and SF3B5 (Ysf3) in yeast, and suggests that the requirement of SF3B5 for cell viability
in Drosophila results from its function in splicing rather than in SAGA.
SF3B5 is not necessary for H3 acetylation
Although SF3B5’s function in splicing is likely to be more critical for cell function, we wondered
whether SF3B5 is also required for any of the known activities of SAGA. SAGA has well
characterized histone modifying activities including its HAT activity toward predominantly
histone H3 Lysine 9 (H3K9ac) and Lysine 14, and deubiquitinase activity against ubH2B. To 
determine if SF3B5 is required for SAGA’s HAT or deubiquitinase activities, we compared levels 
1118of H3K9ac and ubH2B in sf3b5EY12579 mutant larvae with those of wild-type (OregonR or w ) 
larvae. As controls, we also examined ubH2B and H3K9ac levels in nonstop and wda mutants,
which disrupt SAGA deubiquitinase activity and HAT activity resulting in elevated ubH2B levels 
in late third instar larvae, and decreased levels in H3K9ac in embryos respectively [49, 58].
To do this, we first acid extracted histones from wild-type, sf3b5EY12579 and nonstop first instar
larvae and performed western blotting analysis using antibodies against H3K9ac and histone 
H2B (Fig. 5a). Based on this analysis, we find that sf3b5EY12579 larvae show no change in global
H3K9ac levels as compared to wild-type first instar larvae (H3K9ac/H2B ratio is 113% of wild-
type levels) (Fig. 5a). In contrast, mutations in wda that disrupt SAGA HAT activity [49] result in 
a clear decrease in H3K9ac to 51% of wild-type levels (H3K9ac/H2B ratio) by the end of































































































































































          
             
        
         
          
          
        
         
           
         
            
         
      
         
         
            
            
          
         
        
      
        
        
           
           
           
          
       
             
          
         
              
Next, we examined ubH2B levels in sf3b5EY12579 larvae using antibodies specific for ubH2B
relative to histone H3. As a control for the specificity of the ubH2B antibody, we examined
ubH2B levels in acid-extracted histones from sgf11 third instar larvae. Histones from sgf11 third 
instar larvae have ~370% of ubH2B relative to the wild type, indicating that we can detect an
increase in ubH2B in SAGA deubiquitinase mutants [58]. However, neither sf3b5EY12579 nor
nonstop first instar larvae show strong increases in ubH2B levels relative to wild-type larvae
(ubH2B/H3 ratios of 99% and 130% of wild-type levels in sf3b5EY12579 and nonstop respectively)
(Fig. 5a). Previously, we were also unable to detect an increase in ubH2B levels in sgf11 
embryos [36]. These data suggest that it is not possible to detect strong global changes in the
accumulation of ubH2B at first instar larvae when SAGA deubiquitinase activity is defective, 
potentially due to the lag in accumulation of this modification. Thus, based on this analysis, we 
cannot conclude definitively whether SF3B5 is required for SAGA deubiquitinase activity.
SF3B5 is necessary for SAGA-activated expression of some SAGA-regulated genes
Although SF3B5 is not required for SAGA’s HAT activity, it is possible that SF3B5 could function
in transcription coactivation by SAGA independent of histone modification. Several studies in
yeast have shown that SAGA is required for recruitment of the general transcription factors such
as TBP to promoters independent of its HAT activity [66, 67]. In addition, the Drosophila SAGA
subunit SAF6 is required for SAGA-regulated gene expression independent of either HAT or
deubiquitinase activity [40]. Therefore, we sought to determine if SF3B5 is necessary for
SAGA’s function in activating gene expression. To test this, we examined transcript levels of 
SAGA-regulated genes in sf3b5EY12579 embryos using quantitative reverse transcription
polymerase chain reaction (qRT-PCR) analysis. We had previously identified several SAGA-
regulated genes that were co-regulated by the core SAGA subunits SAF6 and WDA in late 
stage embryos [40]. Thus, we compared transcript levels of a subset of these SAGA-regulated
genes in the sf3b5EY12579 embryos with those in wda and wild-type (OregonR) embryos.
First, we examined transcript levels of the SF3B5 and wda genes in each genotype. We 
observe lower transcript levels of SF3B5 and wda genes in the sf3b5EY12579 and wda mutants 
respectively, as compared to the wild type (OregonR). However, levels of RpL32, which has 
previously been shown not to be regulated by SAGA [36, 40, 68], were similar in all three
genotypes (99% and 127% of wild type in wda and sf3b5EY12579 respectively). Notably,
sf3b5EY12579 embryos have about 80% of wild-type levels of transcript encoding the core SAGA

































































































































































































        
    
       
             
           
       
     
      
         
       
           
  
         
             
        
              
            
           
        
       
       
        
           
           
           
           
      
          
         
       
         
       
          
decrease in WDA protein levels since in contrast to wda mutants, H3K9ac levels are not
reduced in sf3b5EY12579 larvae (Fig. 5a).
Next, we examined transcript levels of six SAGA-regulated genes that were previously shown to 
require WDA for full expression in late stage embryos [40]. Notably, four out of the six genes,
Oda, Sap47, exba and Crc, were downregulated in both sf3b5EY12579 and wda embryos relative 
to the wild type (Fig. 5b, Supplemental Table S3). While most of these genes were 
downregulated to similar levels in both mutants relative to the wild type, Sap47 showed
significantly stronger downregulation in sf3b5 relative to wda embryos (Supplemental Table S3).
Interestingly, two of the seven genes examined, CG5390 and Gp150, were significantly
downregulated (p-value < 0.05) in wda embryos but not in sf3b5EY12579 embryos (Fig. 5b, 
Supplemental Table S3). This suggests that SF3B5 is required for full expression of a subset of
SAGA-regulated genes.
Since splicing affects transcript levels, SF3B5 could be required for full expression of these 
SAGA-regulated genes either through its role in SAGA or in the U2 snRNP. Thus, to test
whether loss of SF3B5 affected splicing at these SAGA-regulated genes, we examined levels of 
unspliced transcripts relative to spliced transcripts at Oda, Sap47, exba and Crc (Fig. 5c). To do
this, we generated cDNA using random hexamer primers and performed qRT-PCR with primers
that anneal within an exon and its adjacent intron to amplify an intron/exon boundary (unspliced
transcript). As a control, we used primers that anneal within two adjacent exons to amplify the
spliced transcript. Notably, we observe a large increase in unspliced Sap47 transcript in 
sf3b5EY12579 embryos relative to the wild-type control (Fig. 5c). This is consistent with the
stronger reduction in Sap47 expression in sf3b5EY12579 embryos relative to wda embryos, and
suggests that SF3B5 is required for proper splicing of this SAGA-regulated gene. However, in 
contrast to the results observed for Sap47, we do not detect an increase in unspliced transcript 
levels for three of the SAGA-regulated genes tested, Oda, exba and Crc (Fig. 5c). This result
indicates that SF3B5 is required for full expression of these three genes through its role in 
SAGA rather than in the U2 snRNP.
Next, we asked if SF3B5 would only function to regulate gene expression in the context of
active splicing. To test this, we examined transcript levels of Sas10, which does not contain any
introns, in sf3b5EY12579 embryos. Levels of Sas10 transcripts were significantly lower (p-value <
0.05, Supplemental Table S3) in both sf3b5EY12579 and wda embryos relative to the wild type
(Fig. 5b). This result indicates that SF3B5 can regulate gene expression at genes that lack 































































































































































































             
       
   
   
        
           
         
        
    
        
           
        
        
       
      
         
      
           
               
  
   
  
        
      
           
       
       
          
         
       
       
         
events of intronless genes [69], and since splicing factors can be required for nuclear export of
intronless mRNAs [70], it is possible that SF3B5 regulates Sas10 expression via U2 snRNP-
mediated processing rather than SAGA-regulated transcription. Further studies would be 
required to distinguish between these possibilities.
Together, our observations indicate that SF3B5 is required for proper transcriptional activation 
of a subset of SAGA-regulated genes, independent of active splicing. It is not clear however,
why genes respond differently to SF3B5 relative to other SAGA subunits. Future global analysis 
of the transcriptome of sf3b5EY12579 embryos relative to other SAGA mutants may provide insight 
into the role that SF3B5 plays in SAGA-activated gene expression.
One potential indirect explanation for the decrease in SAGA-regulated gene expression in 
sf3b5EY12579 mutants is if SF3B5 is required for splicing of SAGA subunits, thereby affecting
levels of these proteins. However, our data argue against an indirect role for SF3B5 in affecting
SAGA coactivation activity through regulating levels of SAGA subunits such as WDA. Whereas 
mutations in wda reduce global levels of H3K9ac in late stage embryos (Fig. 5a), we do not
observe a decrease in global levels of histone acetylation in sf3b5EY12579 embryos, suggesting 
that SAGA remains intact and functional with regards to HAT activity and recruitment to gene 
promoters. In addition, transcript levels of the genes encoding the deubiquitinase module of
SAGA, e(y)2, nonstop, sgf11 and Atxn7, are not reduced in sf3b5EY12579 first instar larvae (Fig.
5d). Thus, we conclude that SF3B5 is likely to be required directly for expression of a subset of
SAGA-regulated genes.
SF3B5 is required for SAGA-regulated gene expression independent of histone
acetylation and splicing
In this study we identify the spliceosomal components SF3B3 and SF3B5 as subunits of
Drosophila SAGA. A previous study had identified a potential role for SF3B3 in the recruitment
of SAGA to UV-damaged DNA [20] while this finding was not supported in a second study [21].
However, a second component of the SF3B complex, SF3B1, interacts with BRCA1 following
DNA damage to enhance splicing of BRCA1-target genes [71], also supporting crosstalk
between the DNA damage and spliceosomal machinery. Here, we show that SF3B5 is required
for proper development and cell viability in Drosophila. Notably, our findings indicate that SF3B5 
is required for SAGA-mediated transcriptional activation at a subset of SAGA-regulated genes, 
independent of SAGA’s HAT activity. These observations therefore place SF3B5 in a similar





























































































































































































          
          
        
         
          
          
        
        
          
          
           
           
       
        
        
       
          
             
     
  
    
     
      
        
        
      
           
    
     
          
          
both of SAGA’s histone modifying activities [40]. We cannot exclude the possibility that SF3B5 
is also required for SAGA deubiquitinase activity, since ubH2B levels do not accumulate to
sufficient levels by the larval stage examined. Future studies to examine the requirement of
SF3B5 in ubH2B-deubiquitination will be of interest because ubH2B has been shown to be
important for co-transcriptional splicing. In humans, the ubH2B histone deubiquitinase USP49 is
required for proper splicing of a large number of genes [72]. 
Based on our findings, we conclude that SF3B3 and SF3B5 play dual roles within the cell in 
splicing and in transcription activation by SAGA. There are several precedents for SAGA
subunits that function in other complexes. For example, the HAT component of SAGA, Gcn5, is
shared with the transcription coactivator complex, ATAC [32]. In addition, Sus1 (Drosophila
E(y)2), which is required for SAGA deubiquitinase activity, also functions in RNA export as part
of the TRanscription-Export (TREX) complex [73, 74]. Our findings indicate that similarly to 
these other SAGA subunits that are shared between multiple complexes, SF3B3 and SF3B5
have independent roles in the spliceosome and in SAGA. Despite this independent role, we 
cannot formally exclude the possibility that these subunits mediate transient interactions
between SAGA and the U2 snRNP during co-transcriptional splicing. Further studies to examine 
the SAGA-specific role of SF3B3 and SF3B5 by generating mutations that disrupt the interaction
of these components with SAGA but not the U2 snRNP will be necessary to fully define the role
of these spliceosomal proteins in metazoan SAGA.
Materials and Methods:
Generation of stable cell lines
Drosophila S2 cells were maintained in Hyclone SFX media at 25°C. Stable S2 cell lines 
expressing Spt3 (CG3169, NP_650146), Spt20 (CG17689, NP_648659), SF3B5 (CG11985, 
NP_652189.1) and U2B (sans fille; CG4528, NP_511045.1) in the pRmHa3-CHA2FL2 vector
were generated by co-transfection with pCoBlast (1:10 ratio) using FuGENE HD transfection
reagent (Promega). Selection was carried out in SFX media supplemented with 10% Fetal
Bovine Serum in the presence of 25 - 30 g/mL blastidicin for 2 – 4 weeks.
Affinity purification and MudPIT analysis
Tandem FLAG-HA affinity purification and MudPIT analysis was conducted as described 
previously [40]. Stable S2 cell lines expressing FLAG-HA tagged bait proteins in the pRmHa3-




































































         
           
                  
          
           
            
           
           
        
        
               
          
         
      
              
         
          
     
           
          
            
          
     
           
           
              
             
          
           
           
     

































extracts were prepared from 4 L of cells grown to a density of 1 x 107 cells/mL. Cells were 
harvested by centrifugation, washed in 10 mM HEPEs [Na+], pH 7.5; 140 mM NaCl, and 
resuspended in 40 mL of Buffer I (15 mM HEPEs [Na+] pH 7.5; 10 mM KCl, 5 mM MgCl2; 0.1
mM EDTA; 0.5 mM EGTA; 350 mM sucrose; supplemented with 20 g/mL leupeptin, 20 g/mL
pepstatin and 100 M PMSF). Nuclei were released by Dounce homogenization (40 strokes
with loose pestle) and pelleted by centrifugation at 10,400 x g for 15 min at 4ºC. Nuclei were 
washed once with Buffer I and then resuspended in 20 mL of Extraction Buffer (20 mM HEPEs 
[Na+], pH 7.5; 10% glycerol; 350 mM NaCl; 1 mM MgCl2; 0.1% TritonX-100; supplemented with 
20 g/mL leupeptin, 20 g/mL pepstatin and 100 M PMSF). Nuclei were incubated in 
Extraction Buffer for 1 h at 4ºC with rotation, and the insoluble chromatin fraction was pelleted 
by sequential centrifugation steps at 18,000 x g 10 min 4ºC and 40,000 rpm 1.5 h 4ºC (50.2Ti
rotor, Beckman). For affinity purification, soluble nuclear extracts were diluted to a final salt
concentration of 150 mM NaCl. Where indicated, 250 g/mL RNAse A was added to soluble 
nuclear extract prior to immunoprecipitation. Nuclear extracts were incubated with 200 L 
(packed bead volume) of anti-FLAG M2 agarose (Sigma) for 4 h – 16 h with rotation, then
washed 3 times in Extraction Buffer containing 150 mM NaCl. FLAG-bound proteins were eluted
4 x with 200 L each of Extraction Buffer (150 mM NaCl) containing 0.5 mg/mL FLAG3 peptide
(3XFLAG: NH2-DYKDDDDKGDYKDDDDKGDYKDDDDK-COOH, synthesized by
Macromolecular Core Facility, Penn State College of Medicine) for 10 min at 25°C. Pooled
FLAG-elutions were incubated with 60 L (packed bead volume) of EZview anti-HA affinity gel
(Sigma) for 4 h – 16 h with rotation, then washed 3 times in Extraction Buffer containing 150 mM
NaCl. HA-bound proteins were eluted 6 x with 150 L each of Extraction Buffer (150 mM NaCl)
containing 0.2 mg/mL HA3 peptide (3XHA: NH2-YPYDVPDYAGYPYDVPDYAGYPYDVPDYA-
COOH, synthesized by Macromolecular Core Facility, Penn State College of Medicine) for 10
min at 25°C. HA-elutions were pooled, and 5 – 10% of the pooled elutions (~200 L) were 
treated with 0.1 U benzonase for 30 min at 37ºC, and then precipitated with 200 L of ice-cold
100 mM Tris-HCl, pH 8.5 and 100 L ice-cold trichloroacetic acid for 16 – 24 h at 4ºC.
Precipitated proteins were collected by centrifugation at > 20,000 x g for 30 min at 4ºC and
washed twice in 1 mL of ice-cold acetone, followed by centrifugation at 20,000 x g for 10 min at
4ºC. The identity and relative abundance of proteins present in the tandem FLAG-HA affinity
purifications was determined using MudPIT [39]. Relative protein levels were estimated using



































































































































   
 
      
           
             
         
       
           
           
          
       
     
      
 
         
      
       
         
         
       
      
 
         
         
    
       
        
         
         
      
representing two technical replicates of the MudPIT analysis. Heat maps were generated using
MultiExperiment Viewer (MeV) software.
HAT assays
HAT assays were performed using FLAG-purified SF3B5-complexes and 500 ng HeLa core
histones as substrate as previously described [77]. Each 30 L HAT reaction contains 50 mM
Tris-HCl, pH 8.0, 5% glycerol, 0.1 mM EDTA, pH 8.0, 1 mM DTT, 1 mM PMSF, 0.25 Ci 3H 
Acetyl Coenzyme A (NET290250UC, PerkinElmer), +/- 500 ng HeLa core histones +/- FLAG-
purified SF3B5-complex. Reactions were incubated at 30°C for 30 min and 15 L was spotted
onto P81 phosphocellulose filter paper, washed three times for 5 min each in 50 mM NaHC03 -
NaCO3 buffer, pH 9.2, and rinsed in acetone. Dried P81 filter papers were subjected to 
scintillation counting in 4 mL of ScintiSafe EconoF (FisherChemical). The remaining 15 L of the
HAT reaction was separated by SDS-PAGE (18% gel), stained with Coomassie Brilliant Blue,
incubated with EN3HANCE autoradiography enhancer (PerkinElmer), dried and exposed to X-
ray film for gel fluorography.
Yeast Two-Hybrid
A yeast two-hybrid assay was performed with the Matchmaker Gold Yeast two-hybrid system 
(Clontech). cDNAs were cloned into pGADT7 and pGBKT7 and were validated by sequencing.
For the SF3B3 domain analysis, the Gateway-compatible yeast two-hybrid vectors pGADT7-
GW and pGBKT7-GW were used [78]. Plasmids were transformed into S. cerevisiae Y2Hgold 
and selected for by growth on media lacking leucine and tryptophan. Interaction in the yeast
two-hybrid assay was determined by growth on selective media lacking leucine, tryptophan,
adenine and histidine according to the manufacturer’s instructions.
Genetics
The sf3b5EY12579 1 67c23 CG11985EY12579fly stock, y w ; P59 /TM3, Sb1 Ser1 , was obtained from the
Bloomington Drosophila Stock Center at Indiana University (BL21381). The sf3b5EY12579 mutant
1118was crossed to w ; Drmio/TM3, P{w+mC=GAL4-twi.G}2.3, P{UAS-2xEGFP}AH2.3, Sb1Ser1 
(BL6663) to generate an EGFP balanced stock, which was used to identify homozygous mutant
embryos and larvae as previously described [49]. The SF3B5 cDNA was cloned into the
pUAST-attB vector and transgenic flies were generated using the phiC31 site-specific
integration system in the attP40 site on chromosome 2L [79]. Flies carrying the sf3b5EY12579 





































































































































      
       
     
         
  
       
        
       
       
  
          
         
      
       
      
           
        
      
        
        
         
 
  
          
              
        
           
    
        
        
      
+mDint2y =EPgy2}CG11985EY12579/MKRS) or actin5C-GAL4 (w; P{w+mC=Act5C-GAL4}25FO1,
+mDint2P{w+mC=UAS-GFP.nls}14/CyO; P{w+mC y =EPgy2}CG11985EY12579/MKRS) on chromosome
2 were generated using standard genetic techniques. Recombinant flies carrying the
sf3b5EY12579 allele with FRT82B were generated using standard genetic techniques. Mosaic eyes 
1 * consisting of sf3b5EY12579 , ada2b1 or UAS-GFPnls cells were generated by crossing y w ; 
P{w+m*=GAL4-ey.H}3-8, P{w+mC=UAS-FLP1.D}JD1; P{ry+t7.2=neoFRT}82B P{w+mC=GMR-
d2 1118hid}SS4, l(3)CL-R1/TM2 flies with the following genotypes: (1) y w ;; P{ry+t7.2=neoFRT}82B,
+mDint2 , P{ry+t7.2P{w+mC y =EPgy2}CG11985EY12579/TM6b Tb1 , (2) ada2B1 =neoFRT}82B / TM3 Sb1 
1118Ser1 or (3) w ;; P{ry+t7.2=neoFRT}82B P{w+mC=Ubi-GFP(S65T)nls}3R/TM6B, Tb1 . A complete 
description of fly genotypes used in this study is provided in Supplemental Table S2.
Histone Western Blot
Histones were acid-extracted from chromatin prepared from larvae or embryos using a modified
version of the soluble nuclear extraction protocol as described previously [40]. Briefly, nuclei
were isolated as described for affinity purification and MudPIT analysis with two minor
modifications: miracloth was used to filter extracts prior to centrifugation, and buffers were 
supplemented with 10 mM sodium butyrate. Acid-soluble proteins were extracted from the
insoluble chromatin pellet by incubation with 0.4 M HCl for 45 min at 25ºC, concentrated using
trichloroacetic acid precipitation, and analyzed by SDS-PAGE and western blotting using the
following antibodies: anti-histone H2B (Rabbit, 1:1000, Active Motif #39125), anti-acetylated H3 
Lys-9 (Rabbit, 1:2000, Millipore 07-352), anti-Ubiquityl-Histone H2B antibody (1:3000, Millipore
17-650) and anti-Histone H3 (1:3000. Active Motif 61277). Relative levels of ubH2B/H3 and 
H3K9ac/H2B were quantified using Image Lab Software 5.0 (BioRad) within a single blot or cut
membrane.
qRT-PCR analysis
RNA was isolated using the Zymoprep Direct-zol RNA MicroPrep kit (Zymo Research) and
treated with DNAse I as per the kit protocol. cDNA was generated from 250 ng of RNA using 
Episcript Reverse Transcriptase (Epicentre) using either oligo dTs or random hexamer primers
as indicated. qPCR was conducted using Evagreen 2X Mix (Biotium) and the CFX Connect
Real-time system (Biorad). Quantities were determined relative to a 4-fold dilution series of wild-
type (OregonR) cDNA. Primers against SAGA-regulated genes were taken from previous 
studies [40]. New primers used in this study are as follows: SF3B5 5′-











































































































      
      
     
         
    
  
        
         
     
ACCGGTGCTCAACTACGTTC-3′ and 5′- GCTCCTCGATCAGATCCTTG-3′, Oda (unspliced) 5’-
CCGTGCAAAAAGTGAATGTG-3’ and 5’- GCCAACCTGGAGAACGTCTA -3’, Sap47 (unspliced)
5’-ATCGATATTCCGCTTGTTGC-3’ and 5’- GCGCAAGTTTGATATTGTCG-3’, exba (unspliced)
5’- GAGCCCAAGGACAGGATTG-3’ and 5’- TGCTTGAACGTCTGGAACAG-3’, Crc (unspliced) 5’-
CGGACGAGTTGTCAACAGAA-3’ and 5’- TCTGAAGATGCACCGAATTG-3’.
Accession Numbers
The complete MudPIT dataset (raw files, peak files, search files, as well as DTASelect result
files) can be obtained from the MassIVE database via ftp://massive.ucsd.edu/ using the







































































































































           
      
        
          
         
       
       
             
     
        
         
          
           
        
      
          
         
         
     
             
       
         
           
          
           
           
         
         
         
       
       
          
Figure Legends:
Fig 1. SF3B3 and SF3B5 are novel components of Drosophila SAGA. (a) Heat map
showing the relative spectral abundance of SAGA and spliceosomal subunits expressed as 
dNSAF (distributive normalized spectral abundance factor) in tandem FLAG-HA purifications
from S2 cells using U2B, SF3B5, Ada2B-PB, Spt3, Spt20, ATXN7, Ada1, SAF6, Sgf29 and 
WDA as bait proteins, relative to control purifications from untagged S2 cells (S2 -) or S2 cells 
expressing non-specific tagged protein CG6459. Bait proteins were C-terminally tagged as 
indicated (C). Bait proteins new to this study are highlighted in red. The dNSAF scale is shown 
at the top of panel (a) with the highest abundance subunits represented in yellow, and absent or
under-represented subunits in blue. dNSAF values used to generate the heat map are provided 
in Supplemental Table S1. (b, c) The HAT activity of FLAG-purified SF3B5-complexes was 
assayed in vitro by incorporation of 3H-acetyl CoA into core histones. Core histones and/or
FLAG-purified SF3B5-complex were included in each HAT assay as indicated by +/- below the
graph in panel b, and 3H-acetyl CoA incorporation assayed for each reaction using both 
scintillation counting (b) and fluorography (c). Lanes in panel (c) correspond to reactions from
above (panel b). Reactions containing complex and histones were performed in triplicate and 
compared to background levels of single control reactions lacking histones or complex as part of
the set of HAT assays previously described for WDA- and SAF6-purified SAGA [40]. Error bars 
in panel (b) for + SF3B5-complex + histones represent standard deviation of the mean for three
technical replicates. (c) Histones were separated by SDS-PAGE, stained with Coomassie 
Brilliant Blue (CBB) to determine the migration of each histone (upper panel), and 3H-acetyl CoA
incorporation for each histone examined using fluorography (FL).
Fig 2. SF3B3 and SF3B5 bind SAGA independent of RNA. (a, b) SAGA was FLAG-HA 
purified from S2 cells using WDA as bait protein following treatment of the soluble nuclear
extract with RNAse A. An ethidium bromide stained agarose gel of the soluble nuclear extract
(NE, 10 µL, + and 20 µL, ++) used for immunoprecipitation with and without RNAse treatment
(+/- respectively) is shown in panel (a), and a silver stained SDS-PAGE gel of the purified WDA-
complexes +/- RNAse treatment is shown in panel (b). (c) Peptides from SF3B3 and SF3B5 are 
identified at similar levels in SAGA purifications from S2 cells using WDA as bait in the presence 
and absence of RNAse treatment. Sequence coverage (%) and number of peptides (spectral
count) are shown for each polypeptide, relative to the bait protein WDA.
Fig. 3 SF3B3 and SF3B5 interact with Sgf29 and Spt7 by yeast two-hybrid analysis. (a) 

































































































































































































        
            
          
         
       
       
            
         
           
            
           
          
           
         
           
       
          
             
        
            
           
         
             
            
            
          
         
        
         
        
     
      
         
Gal4 activating domain (AD) with SF3B3 or SF3B5 fused to the Gal4 DNA binding domain 
(DBD). Empty plasmids containing only the activating domain (AD, left column) or DNA binding
domain (DBD, top row) were used to test for auto-activation of each protein. Approximately
30,000 cells were spotted on media lacking leucine, tryptophan, adenine and histidine for each 
tested interaction between AD- and DBD-fusion proteins (boxes). Images are shown for
representative spots for each tested interaction (black boxes) indicating growth or no growth. 
ND, not determined. (b) Protein alignment of SF3B3 in S. cerevisiae (Rse1), D. melanogaster
and H. sapiens. Motifs were identified using Pfam and are shown in grey boxes with the length 
of each domain indicated in parenthesis and percentage similarity for domains between species
shown flanked by dotted lines. The numbers above the proteins denote the amino acids in the
sequence showing placement of the domains. Overall percent sequence similarity for each full-
length protein pair is shown to the right of the schematic. (c) Yeast two-hybrid assay was 
performed as described in panel a. Plasmids used in this panel are gateway compatible vectors
denoted “GW”. SF3B3-FL contains the full length SF3B3 construct, SF3B3-N contains amino
acids 1 - 746 and SF3B3 contains amino acids 747 - 1227 in the pGBKT7-GW plasmid.
Fig 4. SF3B5 is necessary for organismal and cell viability. (a) Schematic representation of
the SF3B5 (CG11985) locus on chromosome 3R showing the position of the P-transposon
EY12579. The single exon of the SF3B5 gene is represented by the grey box. Translated
sequences are filled with grey, and 5' and 3' untranslated regions are shown as open boxes. 
The +1 position corresponds to the ATG of the translation start site. (b) Genetic crosses were 
conducted with flies carrying the UAS-SF3B5 rescue construct or the actin5C-GAL4 driver on
chromosome 2, and the sf3b5EY12579 allele on chromosome 3. Surviving adult progeny were 
scored for the presence of the balancer chromosomes using the curly wing phenotype (CyO)
and the bristle marker stubble (MKRS). The number of surviving adult progeny and the total
number of flies scored are shown for each genotype. (c) Mutant fly eyes were generated using
the GMR-hid technique with the following genotypes, Ubi-nlsGFP (wild type), ada2b and
sf3b5EY12579 . A representative image from a single male fly of each indicated genotype is shown. 
(d) Mean eye widths of mutant fly eyes generated as described in panel (c) were determined for
each indicated genotype. The widths of four separate fly eyes from four independent animals
(one eye per animal) were measured, and standard deviation is indicated by error bars. Full
genotypes of flies are shown in Supplemental Table S2.
Fig 5. SF3B5 is necessary for expression of a subset of SAGA-regulated genes


























































































































         
       
       
     
           
          
           
          
         
         
         
            
        
              
       
 
 
        
          
           
       
        
         
           
         
1118 , WT), nonstop and sf3b5EY12579 (OregonR or w first instar larvae (L1), OregonR and wda
embryos, and OregonR and sgf11 third instar larvae (L3) were analyzed by SDS-PAGE and 
western blotting using antibodies against H3K9ac and H2B, or ubH2B and H3. (b) RNA was 
isolated from OregonR (wild-type), sf3b5EY12579 and wda 18 - 24 h embryos and qRT-PCR was 
performed on oligodT-reverse transcribed cDNA. Mean expression levels are normalized to 
RpL32 and shown relative to OregonR, which is set as 100%. Error bars denote standard error
of the quotient for four biological experiments, and p-values for each comparison determined 
using ANOVA and Tukey’s honest significant difference (HSD) test are shown in Supplemental
Table S3. (c) qRT-PCR was performed as described in panel (b) with random hexamer-reverse
transcribed cDNA and primers designed to amplify exon/intron junctions to detect unspliced
transcripts. Mean expression levels of the ratio of unspliced to spliced transcripts are normalized
to RpL32, and shown relative to OregonR, which is set as 100%. Error bars denote standard
error of the quotient for four biological experiments, and p-values for each comparison are
shown in Supplemental Table S3. (d) qRT-PCR was performed on OregonR and sf3b5 first
instar larvae as described for panel (b). Error bars denote standard error of the quotient for
three biological experiments, and p-values for each comparison are shown in Supplemental
Table S3.
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        Bait: % (spectral count)   
Length 
 (aa) FBgn ID
 CG
 number  Protein U2B  SF3B5 Spt3  Spt20
 FBgn0050390  CG30390  Sgf29  X  25.95%(10)  59.52%(74)  57.44%(97)  289
 FBgn0030891  CG7098  Ada3  X  10.97%(13)  34.53%(59)  32.91%(101)  556
 FBgn0020388  CG4107  Gcn5  X  17.34%(31)  39.98%(162)  51.91%(253)  813
 FBgn0037555  CG9638  Ada2b-PB  X  16.94%(27)  42.88%(91)  44.14%(174)  555
 FBgn0051866  CG31866  Ada1  X  12.66%(8)  39.94%(60)  40.26%(73)  308
 FBgn0031281  CG3883  SAF6  X  17.85%(45)  33.33%(123)  42.4%(153)  717
 FBgn0036374  CG17689  Spt20  X  8.6%(25)  25.2%(385)  36.04%(1423)  1873
 FBgn0037981  CG3169  Spt3  X  15.1%(17)  42.19%(693)  26.56%(149)  384
 FBgn0030874  CG6506  Spt7  X  24.23%(32)  33.43%(210)  36.77%(186)  359
 FBgn0026324  CG3069  TAF10b  X  23.29%(4)  23.29%(16)  18.49%(5)  146
 FBgn0011290  CG17358  TAF12  X  5.63%(1)  36.25%(18)  36.25%(25)  160
 FBgn0000617  CG6474  TAF9  3.96%(1)  32.73%(18)  33.09%(72)  36.69%(74)  278
 FBgn0053554  CG33554  Tra1 (Nipped-A)  X  16.15%(117)  28.02%(344)  45.33%(1364)  3790
 FBgn0039067  CG4448  WDA  X  24.5%(43)  47.51%(240)  48.86%(373)  743
 FBgn0031420  CG9866 ATXN7  X  2.47%(5)  18.02%(46)  33.88%(108)  971
 FBgn0000618  CG15191  E(y)2  X  34.65%(13)  42.57%(25)  51.49%(26)  101
 FBgn0013717  CG4166  Nonstop  X  4.84%(7)  23.76%(64)  28.59%(148)  703
 FBgn0036804  CG13379  Sgf11  X  8.67%(4)  44.9%(73)  44.9%(139)  196
 FBgn0040534  CG11985  SF3B5  83.53%(46)  67.06%(89)  67.06%(33)  83.53%(32)  85
 FBgn0035162  CG13900  SF3B3  54.12%(629)  58.92%(2997)  51.83%(639)  51.02%(715)  1227
 FBgn0031493  CG3605  SF3B2 (SF3b145)
 SF3B4
 37.12%(146)  47.4%(123)  X  X  749
 FBgn0015818  CG3780  (SF3b149/Spx)  28.24%(353)  23.63%(410)  X  X  347
 FBgn0035692  CG13298  SF3B6 (SF3b14a)  49.59%(92)  55.37%(201)  X  X  121
 FBgn0031822  CG9548  PHF5A (SF3b14b)  33.33%(8)  7.21%(1)  X  X  111
 FBgn0031266  CG2807  SF3B1 (SF3b155)  52.76%(557)  54.93%(1200)  X  X  1340
 FBgn0266917  CG16941  SF3A1 (SF3a120)  52.42%(313)  49.74%(340)  X  X  784
 FBgn0014366  CG2925  SF3A3 (SF3a60/noi)  54.27%(337)  56.26%(281)  X  X  503
 FBgn0036314  CG10754   SF3A2 (SF3a66)  46.21%(120)  34.47%(222)  X  X  264
 FBgn0262601  CG5352  SmB  49.25%(354)  29.65%(37)  7.04%(2)  10.55%(1)  199
 FBgn0261933  CG10753  SmD1 (snRNP69D)  52.42%(576)  35.48%(56)  16.13%(5)  16.13%(2)  124
 FBgn0261789  CG1249  SmD2  56.3%(323)  47.9%(39)  X  X  119
 FBgn0023167  CG8427  SmD3  35.76%(773)  6.62%(7)  X  X  151
 FBgn0261790  CG18591  SmE  71.28%(524)  67.02%(51)  15.96%(1)  X  94
 FBgn0000426  CG16792  SmF (DebB)  48.86%(45)  39.77%(13)  X  X  88
 FBgn0261791  CG9742  SmG  57.89%(196)  28.95%(9)  X  X  76
 FBgn0033210  CG1406  U2A  61.89%(320)  57.74%(114)  23.02%(5)  X  265





































































          
          
        
859 Table 1. Sequence coverage (%) and number of peptides (spectral count) for each
860 polypeptide identified in MudPIT analysis of affinity purifications using U2B, SF3B5, Spt3




 number  Protein
  Bait: % (spectral count)
Length 
 (aa)U2B  SF3B5 Spt3  Spt20
 FBgn0050390  CG30390  Sgf29  X  25.95%(10)  59.52%(74)  57.44%(97)  289
 FBgn0030891  CG7098  Ada3  X  10.97%(13)  34.53%(59)  32.91%(101)  556
 FBgn0020388  CG4107  Gcn5  X  17.34%(31)  39.98%(162)  51.91%(253)  813
 FBgn0037555  CG9638  Ada2b-PB  X  16.94%(27)  42.88%(91)  44.14%(174)  555
 FBgn0051866  CG31866  Ada1  X  12.66%(8)  39.94%(60)  40.26%(73)  308
 FBgn0031281  CG3883  SAF6  X  17.85%(45)  33.33%(123)  42.4%(153)  717
 FBgn0036374  CG17689  Spt20  X  8.6%(25)  25.2%(385)  36.04%(1423)  1873
 FBgn0037981  CG3169  Spt3  X  15.1%(17)  42.19%(693)  26.56%(149)  384
 FBgn0030874  CG6506  Spt7  X  24.23%(32)  33.43%(210)  36.77%(186)  359
 FBgn0026324  CG3069  TAF10b  X  23.29%(4)  23.29%(16)  18.49%(5)  146
 FBgn0011290  CG17358  TAF12  X  5.63%(1)  36.25%(18)  36.25%(25)  160
 FBgn0000617  CG6474  TAF9  3.96%(1)  32.73%(18)  33.09%(72)  36.69%(74)  278
 FBgn0053554  CG33554  Tra1 (Nipped-A)  X  16.15%(117)  28.02%(344)  45.33%(1364)  3790
 FBgn0039067  CG4448  WDA  X  24.5%(43)  47.51%(240)  48.86%(373)  743
 FBgn0031420  CG9866 ATXN7  X  2.47%(5)  18.02%(46)  33.88%(108)  971
 FBgn0000618  CG15191  E(y)2  X  34.65%(13)  42.57%(25)  51.49%(26)  101
 FBgn0013717  CG4166  Nonstop  X  4.84%(7)  23.76%(64)  28.59%(148)  703
 FBgn0036804  CG13379  Sgf11  X  8.67%(4)  44.9%(73)  44.9%(139)  196
 FBgn0040534  CG11985  SF3B5  83.53%(46)  67.06%(89)  67.06%(33)  83.53%(32)  85
 FBgn0035162  CG13900  SF3B3  54.12%(629)  58.92%(2997)  51.83%(639)  51.02%(715)  1227
 FBgn0031493  CG3605  SF3B2 (SF3b145)
 SF3B4
 37.12%(146)  47.4%(123)  X  X  749
 FBgn0015818  CG3780  (SF3b149/Spx)  28.24%(353)  23.63%(410)  X  X  347
 FBgn0035692  CG13298  SF3B6 (SF3b14a)  49.59%(92)  55.37%(201)  X  X  121
 FBgn0031822  CG9548  PHF5A (SF3b14b)  33.33%(8)  7.21%(1)  X  X  111
 FBgn0031266  CG2807  SF3B1 (SF3b155)  52.76%(557)  54.93%(1200)  X  X  1340
 FBgn0266917  CG16941  SF3A1 (SF3a120)  52.42%(313)  49.74%(340)  X  X  784
 FBgn0014366  CG2925  SF3A3 (SF3a60/noi)  54.27%(337)  56.26%(281)  X  X  503
 FBgn0036314  CG10754  SF3A2 (SF3a66)  46.21%(120)  34.47%(222)  X  X  264
 FBgn0262601  CG5352  SmB  49.25%(354)  29.65%(37)  7.04%(2)  10.55%(1)  199
 FBgn0261933  CG10753  SmD1 (snRNP69D)  52.42%(576)  35.48%(56)  16.13%(5)  16.13%(2)  124
 FBgn0261789  CG1249  SmD2  56.3%(323)  47.9%(39)  X  X  119
 FBgn0023167  CG8427  SmD3  35.76%(773)  6.62%(7)  X  X  151
 FBgn0261790  CG18591  SmE  71.28%(524)  67.02%(51)  15.96%(1)  X  94
 FBgn0000426  CG16792  SmF (DebB)  48.86%(45)  39.77%(13)  X  X  88
 FBgn0261791  CG9742  SmG  57.89%(196)  28.95%(9)  X  X  76
 FBgn0033210  CG1406  U2A  61.89%(320)  57.74%(114)  23.02%(5)  X  265
 FBgn0003449  CG4528  U2B (snf)  43.06%(2520)  29.17%(87)  X  X  216
         Table 1. Sequence coverage (%) and number of peptides (spectral count) for each
        polypeptide identified in MudPIT analysis of affinity purifications using U2B, SF3B5, Spt3
       and Spt20 as bait proteins. X, protein not identified.
Table 
Figure 1 
Fig 1 Stegeman et al.
(a) (b) 
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Fig 2 Stegeman et al. 
+ ++ + ++ NE 
- - + + RNAse - + RNAse 
(c) 
Bait: WDA 
untreated RNAse treated 
Protein % (spectral count) % (spectral count) 
WDA 65.4% (3488) 66.2% (3396) 
SF3B5 83.5% (99) 67.1% (137) 
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Acetyltransferase Deubiquitinase Spt Proteins TAF Proteins 
(b) 
1002 1327 13611 
Rse1 S. cerevisiae CPSF (330aa) 
42%39% 
1 76 590 872 1194 1227
MMS1 (531aa)SF3B3 D. melanogaster CPSF (336aa) 
93% 79% 86% 
1 76 592 863 1182 1217 























CG11984 CG11986 3R:85C2 
-160 -105 -16 +1 258  300 363 567 
(b) 
UAS-SF3B5 sf3b5 Act-GAL4 sf3b5 
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Fig 5 Stegeman et al.
(a) 
L1 embryos L1 L3 
Figure 5 
